Truven Health Analytics 10-Q 7 May 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2015	7-May-15
Document Information [Line Items]
Entity Registrant Name	Truven Holding Corp.
Entity Central Index Key	1571116
Current Fiscal Year End Date	-19
Entity Filer Category	Non-accelerated Filer
Document Type	10-Q
Document Period End Date	31-Mar-15
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Amendment Flag	FALSE
Entity Common Stock, Shares Outstanding		1
Truven Health Analytics, Inc. [Member]
Document Information [Line Items]
Entity Registrant Name	Truven Health Analytics Inc.
Entity Central Index Key	1571117
Entity Common Stock, Shares Outstanding		1

Unaudited_Interim_Condensed_Co

Unaudited Interim Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Current assets
Cash and cash equivalents	$28,287	$12,604	$12,977	$10,255
Trade and other receivables (less allowances of $1,276 and $1,244, respectively)	103,671	120,214
Prepaid expenses and other current assets	28,220	30,251
Deferred tax assets	443	621
Total current assets	160,621	163,690
Computer hardware and other property, net	34,035	37,435
Developed technology and content, net	129,496	134,078
Goodwill	498,820	498,820
Other identifiable intangible assets, net	369,854	382,879
Other noncurrent assets	15,369	16,187
Total assets	1,208,195	1,233,089
Current liabilities
Accounts payable and accrued expenses	68,468	67,228
Deferred revenue	135,097	129,129
Current portion of long-term debt	6,360	6,360
Capital lease obligation	673	664
Current taxes payable	43	173
Total current liabilities	210,641	203,554
Deferred revenue	6,306	5,456
Capital lease obligation	1,203	1,374
Long-term debt	970,580	971,362
Deferred tax liabilities	443	621
Other noncurrent liabilities	3,420	3,599
Total liabilities	1,192,593	1,185,966
Equity
Common stock—$ 0.01 par value; 1,000 shares authorized, 1 share issued and outstanding at March 31, 2015 and December 31, 2014	0	0
Additional paid-in capital	483,861	483,550
Accumulated deficit	-468,133	-436,123
Foreign currency translation adjustment	-126	-304
Total equity	15,602	47,123
Total liabilities and equity	$1,208,195	$1,233,089

Unaudited_Interim_Condensed_Co1

Unaudited Interim Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, except Share data, unless otherwise specified
Statement of Financial Position [Abstract]
Allowance for doubtful accounts receivables	$1,276	$1,244
Common stock par value (in dollars per share)	$0.01	$0.01
Common stock shares authorized	1,000	1,000
Common stock share issued	1	1
Common stock shares outstanding	1	1

Unaudited_Interim_Condensed_Co2

Unaudited Interim Condensed Consolidated Statements of Comprehensive Loss (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Statement of Comprehensive Income [Abstract]
Revenues, net	$143,173	$118,262
Operating costs and expenses Cost of revenues, excluding depreciation and amortization	-83,829	-70,287
Selling and marketing, excluding depreciation and amortization	-15,934	-13,724
General and administrative, excluding depreciation and amortization	-16,882	-11,285
Depreciation	-5,135	-6,593
Amortization of developed technology and content	-10,809	-9,197
Amortization of other identifiable intangible assets	-13,025	-8,615
Other operating expenses	-10,338	-6,529
Total operating costs and expenses	-155,952	-126,230
Operating loss	-12,779	-7,968
Net interest expense	-18,472	-16,273
Other finance costs	-469	-76
Loss before income taxes	-31,720	-24,317
Benefit from (provision for) income taxes	-290	5,060
Net loss	-32,010	-19,257
Other comprehensive loss:
Foreign currency translation adjustments	178	-139
Total comprehensive loss	($31,832)	($19,396)

Unaudited_Condensed_Consolidat

Unaudited Condensed Consolidated Statements of Cash Flows (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Operating activities
Net loss	($32,010)	($19,257)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation	5,135	6,593
Amortization of developed technology and content	10,809	9,197
Amortization of other identifiable intangible assets	13,025	8,615
Amortization of debt issue costs	734	626
Amortization of debt discount	808	720
Amortization of unfavorable leasehold interest	0	-47
Asset write-off	6,000	4,706
Deferred income tax benefit	0	-5,362
Share-based compensation expense	311	240
Changes in operating assets and liabilities:
Trade and other receivables	16,640	16,000
Prepaid expenses and other current assets	-4,019	-6,028
Accounts payable and accrued expenses	5,746	7,239
Deferred revenue	6,728	7,099
Income taxes	-109	146
Other	-94	130
Net cash provided by operating activities	29,704	30,617
Investing activities
Acquisition - payment of working capital adjustment	-91	0
Capital expenditures	-12,355	-10,299
Net cash used in investing activities	-12,446	-10,299
Financing activities
Principal repayment of senior term loan	-1,590	-1,338
Repayment of revolving credit facility	0	-15,000
Payment of capital lease obligation	-163	-1,120
Net cash used in financing activities	-1,753	-17,458
Effect of exchange rate changes in cash and cash equivalents	178	-138
Net increase in cash and cash equivalents	15,683	2,722
Cash and cash equivalents
Beginning of period	12,604	10,255
End of period	28,287	12,977
Supplemental cash flow disclosures
Interest paid	7,149	6,236
Income taxes paid	$176	$156

Unaudited_Interim_Condensed_Co3

Unaudited Interim Condensed Consolidated Statement of Equity (USD $)	Total	Common stock	Additional paid-in capital	Accumulated deficit	Accumulated other comprehensive loss
In Thousands, unless otherwise specified
Balance at beginning period at Dec. 31, 2014	$47,123	$0	$483,550	($436,123)	($304)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Share-based compensation expense	311		311
Foreign currency translation adjustments	178				178
Net loss	-32,010			-32,010
Balance at ending period at Mar. 31, 2015	$15,602	$0	$483,861	($468,133)	($126)

Description_of_Business_and_Ba

Description of Business and Basis of Presentation	3 Months Ended
	Mar. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Description of Business and Basis of Presentation	Description of Business and Basis of Presentation
	Description of the Business
	Truven Holding was formed on April 20, 2012 by Veritas Capital for the purpose of consummating the Prior Acquisition and has had no operations from inception other than its investment in Truven and its subsidiaries.
	Truven provides analytic solutions and service offerings across the full spectrum of healthcare constituents, including state and federal government agencies, hospitals, health systems, employers, health plans, life sciences companies and consumers. Truven operates and manages its business under two reportable segments: Commercial and Government.
	Basis of Presentation
	These unaudited interim condensed consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim reporting and are consistent with the accounting policies and methods used in preparation of the Company's consolidated financial statements as of December 31, 2014. The preparation of interim condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the interim condensed consolidated financial statements and accompanying notes. Although these estimates are based on management's knowledge of current events and actions that the Company may undertake in the future, actual results could differ from those estimates. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. In the opinion of management, all adjustments (consisting only of normal and recurring adjustments) necessary for a fair statement for the periods presented have been recorded. The results of operations for the three months ended March 31, 2015, are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2015. These financial statements should be read in conjunction with, and have been prepared in conformity with, the accounting principles reflected in the Company’s financial statements and the notes thereto for the year ended December 31, 2014 included in the Form10-K as filed with the Securities and Exchange Commission ("SEC") on March 13, 2015.

Recent_Accounting_Pronouncemen

Recent Accounting Pronouncements	3 Months Ended
	Mar. 31, 2015
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Pronouncements	Recent Accounting Pronouncements
	On April 7, 2015, the Financial Accounting Standards Board ("FASB") issued Accounting Standard Update 2015-03, Simplifying the Presentation of Debt Issuance Costs, which requires debt issuance costs to be presented in the balance sheet as a direct deduction from the associated debt liability. For public business entities, the standard is effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within those fiscal years. For all other entities, the standard is effective for financial statements issued for fiscal years beginning after December 15, 2015, and interim periods within fiscal years beginning after December 15, 2016. Early adoption is permitted for financial statements that have not been previously issued. The new guidance will be applied on a retrospective basis. The Company will adopt the guidance starting on January 1, 2016 on a retrospective basis.
	In May 2014, as part of its ongoing efforts to assist in the convergence of GAAP and International Financial Reporting Standards, the FASB issued a new standard related to revenue recognition. Under the new standard, recognition of revenue occurs when a customer obtains control of promised goods or services in an amount that reflects the consideration to which the entity expects to receive in exchange for those goods or services. In addition, the standard requires disclosure of the nature, amount, timing, and uncertainty of revenue and cash flows arising from contracts with customers. The new standard, as currently issued will be effective beginning January 1, 2017. On April 1, 2015, the FASB voted to propose a one-year deferral to the effective date, but to permit entities to adopt one year earlier if they choose (i.e., the original effective date). The proposal will be subject to the FASB’s due process requirement, which includes a period for public comments. The new standard allows for two methods of adoption: (a) full retrospective adoption, meaning the standard is applied to all periods presented, or (b) modified retrospective adoption, meaning the cumulative effect of applying the new standard is recognized as an adjustment to the opening retained earnings balance. The Company is in the process of determining the adoption method as well as the effects the adoption will have on its consolidated financial statements.

Acquisitions

Acquisitions	3 Months Ended
	Mar. 31, 2015
Business Combinations [Abstract]
Acquisitions	Acquisitions
	Simpler Acquisition
	On April 11, 2014, we acquired Simpler (the "Simpler Transaction"). Simpler provides "Lean" enterprise transformation consulting services. This strategic acquisition combines the Company’s market-leading cost and quality analytics in the commercial segment with Simpler’s performance management consulting capabilities to deliver performance improvement solutions to healthcare and commercial customers. Pursuant to the Simpler purchase agreement, the Company indirectly acquired all of the outstanding equity of Simpler for a purchase price of $81.1 million, including a working capital adjustment of $1.1 million, and the issuance of equity interests by Holdings LLC, the direct parent of the Company, of $3.7 million to Simpler. The related acquisition costs amounted to $3.6 million. The Company financed the acquisition and related costs and expenses through an increase in the Tranche B Term Loans (the "Supplemental Tranche B Term Loans") (see Note 6). The Company and its affiliates did not assume any indebtedness in connection with the Simpler Transaction.
	The following is a summary of the allocation of the purchase price of the Simpler Transaction to the estimated fair values of assets acquired and liabilities assumed in the Simpler Transaction. The allocation of the purchase price is based on management's judgment after evaluating several factors, including a valuation assessment prepared by a third party valuation firm:
		Values recognized at acquisition date
	Trade and other receivables	$	7,560
	Prepaid assets and other current assets	425
	Computer hardware and other property	181
	Other identifiable intangible assets	47,500
	Current liabilities	(2,575		)
	Deferred revenue	(600		)
	Net assets acquired	52,491
	Goodwill on acquisition	28,571
	Net consideration	$	81,062
	Accounts receivable, accounts payable, and liabilities were stated at historical carrying values, given their short-term nature.
	The Company engaged a third party valuation firm to assist in determining the fair values of other identifiable assets and liabilities acquired, including trademarks and trade names, customer relationships, backlogs, non-compete agreements, and deferred revenue.
	Computer hardware and other property have been valued at historical carrying values as management estimated that its replacement costs would not significantly differ from its carrying values.
	Trademarks and trade names have been valued using the relief from royalty method under the income approach to estimate the cost savings that accrue to the Company which would otherwise have gone to pay royalties or license fees on revenues earned through the use of the asset. Using this approach, trademarks and trade names were valued at $8.0 million, with estimated useful lives of 13 years.
	Customer relationships were determined using an income approach, taking into account the expected revenue growth and attrition rates of the customers and the estimated capital charges for the use of other net tangible and identifiable net intangible assets. Using this approach, customer relationships were assigned a value of $21.4 million, with estimated useful lives of 3 to 9 years.
	Backlog was determined using an income approach based on projected backlog as of the acquisition date. Using this approach, backlog was assigned a value of $13.7 million, with an estimated useful life of 1 to 2 years.
	Non-compete agreements were determined using an income approach based on projected lost revenue. Using this approach, non-compete agreements were assigned a value of $4.4 million, with estimated useful lives of 2 to 3 years.
	Deferred revenue has been valued using a cost build-up approach and is calculated as the cost to fulfill the legal performance obligation plus a reasonable profit margin.
	The goodwill recognized upon closing of the Simpler acquisition is attributable mainly to the skill of the acquired work force and Simpler’s position as a provider of services to key constituents of the U.S. market. The total goodwill relating to the Simpler Transaction is tax deductible.
	Simpler's revenue and net loss for the three months ended March 31, 2015, amounted to $13.8 million and $1.5 million, respectively.
	The following unaudited pro forma financial data summarizes the Simpler’s results of operations for the three months ended March 31, 2014 had the acquisition of Simpler occurred as of January 1, 2013:
			Three months ended March 31, 2014
			(Unaudited)
	Revenues, net		$	12,663
	Net loss		1,217
	JWA Acquisition
	On October 31, 2014, we acquired JWA (the "JWA Transaction"), a company that provides "Lean" healthcare consulting services. The Company acquired all of the outstanding equity of JWA for a cash purchase price of $15.3 million, including a $1.2 million working capital adjustment and $0.1 million holdback payment. Truven also agreed to pay $1.9 million in three annual payments as compensation to a former major shareholder of JWA who became Truven's employee, as long as the former major shareholder remained with Truven for the next three years. The related acquisition costs amounted to $0.6 million. The Company and its affiliates did not assume any indebtedness in connection with the JWA Transaction. We financed the acquisition and related costs and expenses through the issuance of the Additional Notes.
	The following is a summary of the allocation of the purchase price of the JWA Transaction to the estimated fair values of assets acquired and liabilities assumed in the JWA Transaction. The allocation of the purchase price is based on management's judgment after evaluating several factors, including a valuation assessment prepared by a third party valuation firm:
		Values recognized at acquisition date
	Trade and other receivables	$	1,462
	Prepaid assets and other current assets	41
	Computer hardware and other property	17
	Other identifiable intangible assets	7,489
	Current liabilities	(607		)
	Deferred revenue	(126		)
	Net assets acquired	8,276
	Goodwill on acquisition	7,020
	Net consideration	$	15,296
	Accounts receivable, accounts payable, liabilities and deferred revenue were stated at historical carrying values, given their short-term nature.
	The Company engaged a third party valuation firm to assist in determining the fair values of other identifiable assets and liabilities acquired, including trademarks and trade names, customer relationships and backlogs.
	Computer hardware and other property have been valued at historical carrying values as management estimated that its replacement costs would not significantly differ from its carrying values.
	Trademarks and trade names have been valued using the relief from royalty method under the income approach to estimate the cost savings that accrue to the Company, which would otherwise have gone to pay royalties or license fees on revenues earned through the use of the asset. Using this approach, trademarks and trade names were valued at $0.3 million, with estimated useful lives of 3 to 5 years.
	Customer relationships were determined using an income approach, taking into account the expected revenue growth and attrition rates of the customers and the estimated capital charges for the use of other net tangible and identifiable net intangible assets. Using this approach, customer relationships were assigned a value of $6.1 million, with estimated useful lives of 10 to 11 years.
	Backlog was determined using an income approach based on projected backlog as of the acquisition date. Using this approach, backlog was assigned a value of $1.0 million, with an estimated useful life of 1 year.
	The goodwill recognized upon closing of the acquisition is attributable mainly to the skill of the acquired work force and JWA’s position as a provider of services to key constituents of the U.S. market. The total goodwill relating to the JWA Transaction is tax deductible.
	JWA's revenue and net income for the three months ended March 31, 2015 amounted to $3.1 million and $0.2 million, respectively.
	The following unaudited pro forma financial data summarizes JWA's results of operations for the three months ended March 31, 2014 had the acquisition of JWA occurred as of January 1, 2013:
				Three months ended March 31, 2014
				(Unaudited)
	Revenues, net			$	2,831
	Net Income			173
	HBE Acquisition
	On November 12, 2014, Truven consummated the acquisition of HBE, a leading provider of stakeholder information that is essential for life sciences companies to gain drug approval, reimbursement, and adoption, for a cash purchase price of $17.2 million, including negative working capital adjustment of $2.8 million (the "HBE Transaction"). The related acquisition costs amounted to $1.2 million.
	The Company financed the acquisition and related costs and expenses through the issuance of the Additional Notes (see Note 6). The Company and its affiliates did not assume any indebtedness in connection with the HBE Transaction.
	The following is a summary of the allocation of the purchase price of the HBE Transaction to the estimated fair values of assets acquired and liabilities assumed in the HBE Transaction. The allocation of the purchase price is based on management's judgment after evaluating several factors, including a valuation assessment prepared by a third party valuation firm:
		Values recognized at acquisition date
	Trade and other receivables	$	7,670
	Prepaid assets and other current assets	768
	Computer hardware and other property	140
	Developed technology and content	4,621
Other identifiable intangible assets	11,278
Other noncurrent assets	67
Current liabilities	(8,604		)
Deferred revenue	(4,249		)
Net assets acquired	11,691
Goodwill on acquisition	5,552
Net consideration	$	17,243
Adjustment recorded during the quarter reduced current assets by $0.3 million and increased total liabilities by $0.1 million, as a result of the final working capital adjustment.
Accounts receivable, accounts payable, and liabilities were stated at historical carrying values, given their short-term nature.
The Company engaged a third party valuation firm to assist in determining the fair values of other identifiable assets and liabilities acquired, including trademarks and trade names, customer relationships, non-compete agreements, and deferred revenue.
Computer hardware and other property have been valued at historical carrying values as management estimated that its replacement costs would not significantly differ from its carrying values.
Trademarks and trade names have been valued using the relief from royalty method under the income approach to estimate the cost savings that accrue to the Company which would otherwise have gone to pay royalties or license fees on revenues earned through the use of the asset. Using this approach, trademarks and trade names were valued at $2.5 million, with estimated useful lives of 12 to 14 years.
Customer relationships were determined using an income approach, taking into account the expected revenue growth and attrition rates of the customers and the estimated capital charges for the use of other net tangible and identifiable net intangible assets. Using this approach, customer relationships were assigned a value of $8.8 million, with estimated useful lives of 9 to 11 years.
Deferred revenue has been valued using a cost build-up approach and is calculated as the cost to fulfill the legal performance obligation plus a reasonable profit margin.
The goodwill recognized upon closing of the acquisition is attributable mainly to the skill of the acquired work force and HBE’s position as a provider of services to key constituents of the global life sciences market. The total goodwill relating to the HBE Transaction is tax deductible.
HBE's revenue and net loss for the three months ended March 31, 2015, amounted to $2.8 million and $1.8 million respectively.
The following unaudited pro forma financial data summarizes HBE’s results of operations for the three months ended March 31, 2014 had the acquisition of HBE occurred as of January 1, 2013:
		Three months ended March 31, 2014
		(Unaudited)
Revenues, net		$	5,444
Net income		992

Goodwill

Goodwill	3 Months Ended
	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill
	The changes in the carrying amount of goodwill by reportable segment during the three months ended March 31, 2015, were as follows:
		Commercial			Government			Total
	Balance as of March 31, 2015 and December 31, 2014	$	774,184		$	91,298		$	865,482
	Accumulated impairment:
	Balance as of March 31, 2015 and December 31, 2014	(321,064		)	(45,598		)	(366,662		)
	Net book value as of March 31, 2015 and December 31, 2014	$	453,120		$	45,700		$	498,820

Other_Identifiable_Intangible_

Segment Information	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Segment Information	Segment Information
	The determination of reportable segments was based on the discrete financial information provided to the Chief Operating Decision Maker (the "CODM"). The Chief Executive Officer has the authority for resource allocation and assessment of the Company’s performance and is, therefore, the CODM. The Company’s segment structure enables us to more effectively focus on business and market facing opportunities and to simplify our business decision-making process. The Company's reportable segments are as follows:
	Commercial
	The Commercial segment provides analytic solutions and services to improve the cost, quality, and effectiveness of healthcare for commercial organizations across the healthcare industry including providers, integrated delivery networks, insurers, professional services organizations, healthcare exchanges and employers.
	Government
	The Government segment provides integrated analytic solutions and services to improve the cost, quality, and effectiveness of healthcare for federal and state agencies (e.g. Centers for Medicare & Medicaid Services and state Medicaid agencies) and federally owned and operated healthcare facilities.  Our sales and client services are tailored to meet the specific procurement, sales and support requirements of the government market.
	The CODM evaluates the performance of our segments based on segment operating income (loss), which is calculated internally as net sales, less cost of operations (including allocation of technology costs), selling and marketing, and general and administrative expenses, excluding depreciation and amortization.
	Center/shared services consist of items that are not directly attributable to reportable segments, such as corporate administrative costs and elimination of intercompany transactions.
	Corporate expenses may include other non-recurring or non-operational activity that the CODM excludes in assessing operating segment performance. These expenses, along with depreciation and amortization, other operating income/expense and other non-operating activity such as interest expense/income, are not considered in the measure of the segments’ operating performance, but are shown herein as reconciling items to the Company’s consolidated loss before income taxes.
	The accounting policies for the reportable segments are the same as those for the consolidated Company. The Company’s operations and customers are based primarily in the United States.
	Segment information for the three months ended March 31, 2015 and 2014 is as follows:
		Three months ended March 31,
		2015						2014
		Revenue			Segment operating income			Revenue		Segment operating income
	Commercial	$	118,380		$	35,536		$	96,350	$	29,957
	Government	25,135			(1,277		)	21,912		(641		)
	Segment totals	143,515			34,259			118,262		29,316
	Center/Shared services	(341		)	(7,731		)	—		(6,350		)
	Segment operating income	$	143,174		$	26,528		$	118,262	$	22,966
	Segment operating Margin				19		%			19		%
	The following table reconciles unaudited condensed segment operating income per the reportable segment information to loss before income taxes per the unaudited interim condensed consolidated statements of comprehensive loss.
		Three months ended March 31,
		2015			2014
	Segment operating income	$	26,528		$	22,966
	Depreciation	(5,135		)	-6,593
	Amortization of developed technology and content	(10,809		)	-9,197
	Amortization of other identifiable intangible assets	(13,025		)	-8,615
	Other operating expenses	(10,338		)	(6,529		)
	Operating income	(12,779		)	(7,968		)
	Net interest expense	(18,472		)	(16,273		)
	Other finance costs	(469		)	(76		)
	Loss before income taxes	$	(31,720	)	$	(24,317	)
	Reportable segment asset information is not disclosed because it is not reviewed by the CODM for purposes of evaluating performance and allocating resources.

Longterm_Debt

Segment Information	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Segment Information	Segment Information
	The determination of reportable segments was based on the discrete financial information provided to the Chief Operating Decision Maker (the "CODM"). The Chief Executive Officer has the authority for resource allocation and assessment of the Company’s performance and is, therefore, the CODM. The Company’s segment structure enables us to more effectively focus on business and market facing opportunities and to simplify our business decision-making process. The Company's reportable segments are as follows:
	Commercial
	The Commercial segment provides analytic solutions and services to improve the cost, quality, and effectiveness of healthcare for commercial organizations across the healthcare industry including providers, integrated delivery networks, insurers, professional services organizations, healthcare exchanges and employers.
	Government
	The Government segment provides integrated analytic solutions and services to improve the cost, quality, and effectiveness of healthcare for federal and state agencies (e.g. Centers for Medicare & Medicaid Services and state Medicaid agencies) and federally owned and operated healthcare facilities.  Our sales and client services are tailored to meet the specific procurement, sales and support requirements of the government market.
	The CODM evaluates the performance of our segments based on segment operating income (loss), which is calculated internally as net sales, less cost of operations (including allocation of technology costs), selling and marketing, and general and administrative expenses, excluding depreciation and amortization.
	Center/shared services consist of items that are not directly attributable to reportable segments, such as corporate administrative costs and elimination of intercompany transactions.
	Corporate expenses may include other non-recurring or non-operational activity that the CODM excludes in assessing operating segment performance. These expenses, along with depreciation and amortization, other operating income/expense and other non-operating activity such as interest expense/income, are not considered in the measure of the segments’ operating performance, but are shown herein as reconciling items to the Company’s consolidated loss before income taxes.
	The accounting policies for the reportable segments are the same as those for the consolidated Company. The Company’s operations and customers are based primarily in the United States.
	Segment information for the three months ended March 31, 2015 and 2014 is as follows:
		Three months ended March 31,
		2015						2014
		Revenue			Segment operating income			Revenue		Segment operating income
	Commercial	$	118,380		$	35,536		$	96,350	$	29,957
	Government	25,135			(1,277		)	21,912		(641		)
	Segment totals	143,515			34,259			118,262		29,316
	Center/Shared services	(341		)	(7,731		)	—		(6,350		)
	Segment operating income	$	143,174		$	26,528		$	118,262	$	22,966
	Segment operating Margin				19		%			19		%
	The following table reconciles unaudited condensed segment operating income per the reportable segment information to loss before income taxes per the unaudited interim condensed consolidated statements of comprehensive loss.
		Three months ended March 31,
		2015			2014
	Segment operating income	$	26,528		$	22,966
	Depreciation	(5,135		)	-6,593
	Amortization of developed technology and content	(10,809		)	-9,197
	Amortization of other identifiable intangible assets	(13,025		)	-8,615
	Other operating expenses	(10,338		)	(6,529		)
	Operating income	(12,779		)	(7,968		)
	Net interest expense	(18,472		)	(16,273		)
	Other finance costs	(469		)	(76		)
	Loss before income taxes	$	(31,720	)	$	(24,317	)
	Reportable segment asset information is not disclosed because it is not reviewed by the CODM for purposes of evaluating performance and allocating resources.

Other_Operating_Expenses

Segment Information	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Segment Information	Segment Information
	The determination of reportable segments was based on the discrete financial information provided to the Chief Operating Decision Maker (the "CODM"). The Chief Executive Officer has the authority for resource allocation and assessment of the Company’s performance and is, therefore, the CODM. The Company’s segment structure enables us to more effectively focus on business and market facing opportunities and to simplify our business decision-making process. The Company's reportable segments are as follows:
	Commercial
	The Commercial segment provides analytic solutions and services to improve the cost, quality, and effectiveness of healthcare for commercial organizations across the healthcare industry including providers, integrated delivery networks, insurers, professional services organizations, healthcare exchanges and employers.
	Government
	The Government segment provides integrated analytic solutions and services to improve the cost, quality, and effectiveness of healthcare for federal and state agencies (e.g. Centers for Medicare & Medicaid Services and state Medicaid agencies) and federally owned and operated healthcare facilities.  Our sales and client services are tailored to meet the specific procurement, sales and support requirements of the government market.
	The CODM evaluates the performance of our segments based on segment operating income (loss), which is calculated internally as net sales, less cost of operations (including allocation of technology costs), selling and marketing, and general and administrative expenses, excluding depreciation and amortization.
	Center/shared services consist of items that are not directly attributable to reportable segments, such as corporate administrative costs and elimination of intercompany transactions.
	Corporate expenses may include other non-recurring or non-operational activity that the CODM excludes in assessing operating segment performance. These expenses, along with depreciation and amortization, other operating income/expense and other non-operating activity such as interest expense/income, are not considered in the measure of the segments’ operating performance, but are shown herein as reconciling items to the Company’s consolidated loss before income taxes.
	The accounting policies for the reportable segments are the same as those for the consolidated Company. The Company’s operations and customers are based primarily in the United States.
	Segment information for the three months ended March 31, 2015 and 2014 is as follows:
		Three months ended March 31,
		2015						2014
		Revenue			Segment operating income			Revenue		Segment operating income
	Commercial	$	118,380		$	35,536		$	96,350	$	29,957
	Government	25,135			(1,277		)	21,912		(641		)
	Segment totals	143,515			34,259			118,262		29,316
	Center/Shared services	(341		)	(7,731		)	—		(6,350		)
	Segment operating income	$	143,174		$	26,528		$	118,262	$	22,966
	Segment operating Margin				19		%			19		%
	The following table reconciles unaudited condensed segment operating income per the reportable segment information to loss before income taxes per the unaudited interim condensed consolidated statements of comprehensive loss.
		Three months ended March 31,
		2015			2014
	Segment operating income	$	26,528		$	22,966
	Depreciation	(5,135		)	-6,593
	Amortization of developed technology and content	(10,809		)	-9,197
	Amortization of other identifiable intangible assets	(13,025		)	-8,615
	Other operating expenses	(10,338		)	(6,529		)
	Operating income	(12,779		)	(7,968		)
	Net interest expense	(18,472		)	(16,273		)
	Other finance costs	(469		)	(76		)
	Loss before income taxes	$	(31,720	)	$	(24,317	)
	Reportable segment asset information is not disclosed because it is not reviewed by the CODM for purposes of evaluating performance and allocating resources.

Segment_Information

Segment Information	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Segment Information	Segment Information
	The determination of reportable segments was based on the discrete financial information provided to the Chief Operating Decision Maker (the "CODM"). The Chief Executive Officer has the authority for resource allocation and assessment of the Company’s performance and is, therefore, the CODM. The Company’s segment structure enables us to more effectively focus on business and market facing opportunities and to simplify our business decision-making process. The Company's reportable segments are as follows:
	Commercial
	The Commercial segment provides analytic solutions and services to improve the cost, quality, and effectiveness of healthcare for commercial organizations across the healthcare industry including providers, integrated delivery networks, insurers, professional services organizations, healthcare exchanges and employers.
	Government
	The Government segment provides integrated analytic solutions and services to improve the cost, quality, and effectiveness of healthcare for federal and state agencies (e.g. Centers for Medicare & Medicaid Services and state Medicaid agencies) and federally owned and operated healthcare facilities.  Our sales and client services are tailored to meet the specific procurement, sales and support requirements of the government market.
	The CODM evaluates the performance of our segments based on segment operating income (loss), which is calculated internally as net sales, less cost of operations (including allocation of technology costs), selling and marketing, and general and administrative expenses, excluding depreciation and amortization.
	Center/shared services consist of items that are not directly attributable to reportable segments, such as corporate administrative costs and elimination of intercompany transactions.
	Corporate expenses may include other non-recurring or non-operational activity that the CODM excludes in assessing operating segment performance. These expenses, along with depreciation and amortization, other operating income/expense and other non-operating activity such as interest expense/income, are not considered in the measure of the segments’ operating performance, but are shown herein as reconciling items to the Company’s consolidated loss before income taxes.
	The accounting policies for the reportable segments are the same as those for the consolidated Company. The Company’s operations and customers are based primarily in the United States.
	Segment information for the three months ended March 31, 2015 and 2014 is as follows:
		Three months ended March 31,
		2015						2014
		Revenue			Segment operating income			Revenue		Segment operating income
	Commercial	$	118,380		$	35,536		$	96,350	$	29,957
	Government	25,135			(1,277		)	21,912		(641		)
	Segment totals	143,515			34,259			118,262		29,316
	Center/Shared services	(341		)	(7,731		)	—		(6,350		)
	Segment operating income	$	143,174		$	26,528		$	118,262	$	22,966
	Segment operating Margin				19		%			19		%
	The following table reconciles unaudited condensed segment operating income per the reportable segment information to loss before income taxes per the unaudited interim condensed consolidated statements of comprehensive loss.
		Three months ended March 31,
		2015			2014
	Segment operating income	$	26,528		$	22,966
	Depreciation	(5,135		)	-6,593
	Amortization of developed technology and content	(10,809		)	-9,197
	Amortization of other identifiable intangible assets	(13,025		)	-8,615
	Other operating expenses	(10,338		)	(6,529		)
	Operating income	(12,779		)	(7,968		)
	Net interest expense	(18,472		)	(16,273		)
	Other finance costs	(469		)	(76		)
	Loss before income taxes	$	(31,720	)	$	(24,317	)
	Reportable segment asset information is not disclosed because it is not reviewed by the CODM for purposes of evaluating performance and allocating resources.

Sharebased_Compensation

Share-based Compensation	3 Months Ended
	Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Share-based Compensation	Share-based Compensation
	In October 2012, the Company’s immediate parent, Holdings LLC, established a compensation award in accordance with the Operating Agreement to provide Class B Membership Interests in Holdings LLC to certain executive officers of the Company, not to exceed 6.25% in the aggregate. On April 11, 2014, Holdings LLC amended the Operating Agreement to provide Class B-1 Membership Interests in Holdings LLC to Simpler executives. Class B and B-1 membership interests ("Membership Interests") will both vest 20% on each of the first five anniversaries, subject to certain conditions. In addition, 100% of Membership Interests may vest in certain circumstances in connection with a change in control as defined in the Operating Agreement. Each Membership Interest has the right to receive a percentage of the distribution made by Holdings LLC when the distribution is actually made if such distributions exceed specified internal rates of return thresholds.
	There are transfer restrictions on the Membership Interests and the executive officers would forfeit the unvested interest upon termination of employment. A summary of the Membership Interests is as follows:
		Class B			Class B-1
		Ownership interest (%)	Fair value at grant date		Ownership interest (%)	Fair value at grant date
	Total outstanding balance at December 31, 2014 and March 31, 2015	4.4	$	6,100	0.9	$	1,067
	Total vested as of March 31, 2015	1.7	$	2,391	—	$	—
	The fair value at the date of grant was based upon the value of the Membership Interests of Holdings LLC less a marketability discount since there is no active market to trade Membership Interests. The marketability discount was determined using a geometric average rate put option model and a Black-Scholes put option model using the expected term, risk-free rate, and volatility for liquidity terms. The value was determined as of the grant date based upon a number of factors, including the amount of investment made in exchange for Membership Interests of Holdings LLC by Veritas Capital and certain members of management of the Company.
	The Company recognized compensation expense, net of estimated forfeiture rate of 10% against additional paid in capital of $311 and $240, for the three months ended March 31, 2015 and 2014, respectively, which is recorded in General and administrative expense in the Company’s unaudited interim condensed consolidated statements of comprehensive loss. There were no membership grants during the three months ended March 31, 2015 and 2014.
	The total unrecognized compensation cost related to nonvested Membership Interests expected to be recognized over the next 4.3 years is $3,308.
	As of March 31, 2015, 1.7% of Class B Membership Interests have vested with an estimated fair value of $2,039. There were no Class B-1 Membership Interest that vested as of March 31, 2015.

Related_Party_Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2015
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions
	The Company entered into an advisory agreement with the Sponsor, under which the Sponsor provided certain advisory services to the Company. As compensation for the services, the Company paid a transaction fee at the closing of the Prior Acquisition and will continue to pay the Sponsor an annual advisory fee in an aggregate amount equal to the greater of (i) $2.5 million or (ii) 2.0% of consolidated EBITDA (as defined in the Senior Credit Agreement), as well as transaction fees on future acquisitions, divestitures, financings and liquidity events, which will be determined based upon aggregate equity investments at the time of such future events or on the value of the transaction. For the three months ended March 31, 2015 and 2014, the Company recorded an expense for the Sponsor fee of $1.0 million and $0.6 million, respectively. The Sponsor advisory fee is presented within other operating expenses in the Company's unaudited interim condensed consolidated statements of comprehensive loss. As of March 31, 2015, the Company had sponsor fee payable of $0.3 million included in the accounts payable and accrued expenses account in the balance sheet.
	The Company has a sublease arrangement with Thomson Reuters U.S. Inc. as part of the reverse transitional services agreement entered into in connection with the Prior Acquisition. The sublease income recognized for the three months ended March 31, 2015 and 2014 totaled $0.1 million and $0.1 million, respectively. These were recorded as a reduction to general and administrative expense in the Company's unaudited interim condensed consolidated statements of comprehensive loss.
	As part of the Simpler Transaction (see Note 3), the issuance by Holdings LLC of $3,730 of equity interests to Simpler has been accounted for as additional capital contribution.
	On October 11, 2013, the Company received a note receivable of $0.3 million from Holdings LLC, the direct parent company of the Company. The note receivable bears interest at a rate per annum of 1.9%. Interest is payable in arrears on each October 15, commencing on October 15, 2014. In lieu of paying in cash for the interest payments, any accrued but unpaid interest shall be capitalized and added as of such interest payment date to the principal amount of the note receivable. At any time, Holdings LLC may redeem all or any part of the note receivable at a redemption price equal to 100% of the principal amount redeemed plus all interest accrued and unpaid through the redemption date. The note receivable is included in trade and other receivables account in the balance sheet as of March 31, 2015.

Income_Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2015
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes
	Income tax provisions for interim periods are based on estimated annual income tax rates, adjusted to reflect the effects of any significant infrequent or unusual items which are required to be discretely recognized within the current interim period. The Company’s intention is to permanently reinvest its foreign earnings outside of the United States. As a result, the effective tax rates in the periods presented are largely based upon the projected annual pre-tax earnings by jurisdiction and the allocation of certain expenses in various taxing jurisdictions where the Company conducts its business. These taxing jurisdictions apply a broad range of statutory income tax rates.
	Income tax provision for the three months ended March 31, 2015 had an effective tax rate of (0.9)%, which is different from the amount derived by applying the federal statutory tax rate of 35%, mainly due to the impact of certain state taxes and tax credits partially offset by non-deductible expenses and valuation allowance of $8.0 million recorded against the Company's net deferred tax asset as it is not more likely than not that the net deferred tax asset will be realized. Income tax benefit for the three months ended March 31, 2014, at an effective tax rate of 20.8%, is different from the amount derived by applying the federal statutory tax rate of 35%, mainly due to the impact of certain state income taxes partially offset by the impact of non-deductible expenses. The Company and its subsidiaries are subject to U.S. federal income tax as well as income taxes of multiple states and foreign jurisdictions.

Commitment_and_Contingencies

Commitment and Contingencies	3 Months Ended
	Mar. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitment and Contingencies
	Security and Guarantee Agreements
	The Company has entered into guarantee and security arrangements in respect of its indebtedness as described in Note 6.
	Contractual Commitments
	Revenue Sharing Agreement
	Effective January 1, 2013, the Company modified its agreement with a supplier under which it markets and licenses to its customers a private label version of the supplier's platform solution in conjunction with the Company's health information applications. The agreement contains a revenue share arrangement based on net revenue targets. The supplier's revenue share percentage is guaranteed by the Company in the minimum amounts of $2.0 million, $4.0 million and $6.0 million, for the calendar years 2013, 2014 and 2015, respectively. The guaranteed revenue share is paid in advance by the Company on March 1st of each calendar year and is applied against the revenue share of the supplier earned through March 1st of the following calendar year. The agreement provides a grace period for the Company of up to August 31st of the following calendar year in the event that the supplier's revenue share earned does not reach the prepayment amount. After the grace period, if the revenue share earned does not meet the minimum target then the entire prepayment amount is deemed earned by the supplier. During the first quarters of 2015 and 2014, the Company wrote off $6.0 million and $4.7 million of the prepaid balance, respectively, as it was determined that the estimated revenue share of the supplier will not be met within the grace period. As of March 31, 2015, there are no prepaid revenue share balances on the Company's balance sheet.
	Litigation and Legal Proceedings
	Truven has been named as a defendant in over 200 separate pharmaceutical tort lawsuits relating to the use of Reglan or its generic version, the first of which was filed by June 2010 and the rest of which were filed in March 2012. All of these actions are pending in the Court of Common Pleas in Philadelphia County, Pennsylvania. In these matters, the plaintiffs allege that they sustained various injuries (including neurological disorders) as a result of their ingestion of Reglan. While a host of drug manufacturers and pharmacies are named as defendants in each of the suits, claims have also been asserted against so-called “Patient Education Monograph” (“PEM”) defendants, including us. It is generally alleged in all of the actions that certain PEM defendants provided Reglan patient drug information to pharmacies which, in turn, provided that drug information to the pharmacies' customers, the plaintiffs in these actions. Plaintiffs further allege that the PEM defendants' patient drug information did not provide adequate warning information about the use of Reglan. Other PEM defendants have also been named in these and other similar actions. In general, the lawsuits have been procedurally consolidated in Philadelphia as mass tort actions. To date, none of the actions against Truven specifically identifies Truven as the author of a PEM that was supplied to a plaintiff. Instead, plaintiffs in these cases allege only that they read an unnamed PEM and, in effect, that it must have been published by at least one of the PEM defendants named in the action.
	Along with other PEM defendants, Truven made one dispositive motion to dismiss all the actions. While that motion to dismiss has been denied, it was without prejudice, permitting Truven to renew at a later stage in the litigation.
	Pending the resolution of appeals by the co-defendant generic drug company defendants, the resolution of which will not affect the continuation of the actions against us, there has been no active discovery involving Truven. At this time, we believe that we have meritorious defenses to the claims in each of these actions.
	On December 15, 2011, Midwest Health Initiative, a client of our research business, requested arbitration of a dispute relating to our performance under a client services agreement. The arbitration proceedings were initiated in St. Louis and were settled by both parties during the fourth quarter of 2013. The settlement amount was immaterial.
	Pacific Alliance Medical Center (“PAMC”) claimed in 2007 that we failed to properly submit some of PAMC’s data, resulting in denial of Medicare reimbursement to PAMC in the approximate amount of $600,000. PAMC was denied relief by administrative agencies and appealed to the U.S. District Court in the Central District of California for judicial review, which was denied. PAMC later appealed to the United States Court of Appeals for the Ninth Circuit which affirmed the District Court's decision. The parties have entered into a tolling agreement pending the outcome of PAMC’s appeals. If a claim is filed against us, we expect to defend it.
	Truven filed U.S. trademark applications for the trademarks Truven Health Analytics and Truven Health Unify.  In May 2013 and March 2014, respectively, Truveris, Inc. (“Truveris”) filed notices of opposition against these applications in the Trademark Trial and Appeal Board of the United States Patent and Trademark Office alleging that the Truven Health Analytics and Truven Health Unify applications create a likelihood of confusion with Truveris’s alleged common law trademark Truveris as well as its registered trademarks Trubid, Truguard, Trubuy, Trureport and Trurxpay.  Truveris has also alleged that Truven’s use of the Truven alleged mark is likely to cause confusion with Truveris’s alleged trademark.  We plan to vigorously defend these claims.
	The Company is involved in other litigation proceedings arising from the normal course of its operations. Related reserves are recorded when it is probable that liabilities exist and where reasonable estimates of such liabilities can be made.
	While it is not possible to predict the outcome of any of these proceedings, the Company's management, in conjunction with its legal advisors, based on its assessment of the facts and circumstances now known, does not believe that any of these proceedings, individually or in the aggregate, will have a material adverse effect on the Company's financial position, results of operations and cash flows.

Fair_Value_Measurement

Fair Value Measurement	3 Months Ended
	Mar. 31, 2015
Fair Value Disclosures [Abstract]
Fair Value Measurement	Fair Value Measurement
	Fair value is defined under the Fair Value Measurements and Disclosures Topic of the Codification, FASB ASC 820, as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value under FASB ASC 820 must maximize the use of observable inputs and minimize the use of unobservable inputs. The standard established a fair value hierarchy based on three levels of inputs, of which the first two are considered observable and the last unobservable, as follows:
	• Level 1—Quoted prices in active markets for identical assets or liabilities. These are typically obtained from real-time quotes for transactions in active exchange markets involving identical assets.
	• Level 2—Inputs, other than quoted prices included within Level 1, which are observable for the asset or liability, either directly or indirectly. These are typically obtained from readily-available pricing sources for comparable instruments.
	• Level 3—Unobservable inputs, where there is little or no market activity for the asset or liability. These inputs reflect the reporting entity’s own assumptions of the data that market participants would use in pricing the asset or liability, based on the best information available in the circumstances.
	Under the Financial Instruments Topic of the Codification, ASC 825, entities are permitted to choose to measure many financial instruments and certain other items at fair value. The Company did not elect the fair value measurement option under ASC 825 for any of its financial assets or liabilities.
	The Company has determined that the fair value of accounts receivable and accounts payable approximates carrying value at March 31, 2015 and December 31, 2014 due to short term maturity dates.
	At March 31, 2015, the carrying amounts and fair values of the Senior Credit Facility and 10.625% Senior Notes were as follows:
			Fair values
		Carrying amounts	Level 1		Level 2		Level 3
	Senior Term Loan	610,051	$	—	$	625,596	$	—
	10.625% Senior Notes	366,889	—		386,425		—
	At December 31, 2014, the carrying amounts and fair values of the Senior Credit facility and 10.625% Senior Notes were as follows:
			Fair values
		Carrying amounts	Level 1		Level 2		Level 3
	Senior Term Loan	610,845	$	—	$	603,009	$	—
	10.625% Senior Notes	366,877	—		357,971		—
	Our level 2 inputs are determined based on quoted prices for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant inputs are observable in the market or can be corroborated by observable market data for substantially the full term of the liabilities. Where applicable, these models project future cash flows and discount the future amounts to a present value using market-based observable inputs including interest rate curves.

Supplemental_Guarantor_Financi

Supplemental Guarantor Financial Information	3 Months Ended
	Mar. 31, 2015
Condensed Financial Information of Parent Company Only Disclosure [Abstract]
Unaudited Supplemental Guarantor Financial Information	Supplemental Guarantor Financial Information
	Truven has issued the Notes as further described in Note 6. The Notes are fully and unconditionally guaranteed, jointly and severally, on a senior unsecured basis by Truven Holding Corp. and each of Truven’s existing and future 100% owned domestic restricted subsidiaries that is a borrower under or that guarantees the obligations under the Senior Credit Facility or any other indebtedness of Truven or any other guarantor. All obligations under the Senior Credit Facility are also guaranteed by Truven Holding Corp. and each of Truven’s 100% owned domestic subsidiaries. All obligations under the Senior Credit Facility and the guarantees of those obligations are secured by first priority security interests in substantially all of Truven’s assets, as well as those of each guarantor (subject to certain limited exceptions).
	Prior to the series of acquisitions in 2014, the separate financial statements and the condensed consolidating and combining financial information about the comprehensive loss, financial position and cash flows of the Parent, the Issuer, the Guarantors, the non-Guarantors, and eliminations were not presented due to the following:
	•	Truven (the Issuer) is 100% owned by Truven Holding Corp. (the parent company guarantor).
	•	The guarantee by Truven Holding Corp. is full and unconditional and there were no subsidiary guarantors.
	•	Truven Holding Corp. has no independent assets or operations.
	•	The transaction costs related to the Prior Acquisition of $26,734 were incurred and paid for by Wolverine, which was merged with and into TRHI, with TRHI surviving the Merger upon closing of the Prior Acquisition as a 100% owned direct subsidiary of Truven Holding Corp. and subsequently changing its name to Truven Health Analytics Inc.
	•	The subsidiaries of Truven Holding Corp. other than Truven were minor (as defined in Section 3-10(h)(6) of Regulation S-X of the U.S. Securities Act of 1933, as amended (the “Securities Act”), having total assets, stockholders’ equity, revenues, operating income (before income taxes) and cash flows from operating activities of less than 3% of the Company’s corresponding consolidated amounts.
	After the series of acquisitions, certain acquired 100% owned domestic subsidiaries became guarantors of the obligations of Truven under the Senior Credit Facility and the Notes starting in second quarter of 2014. In accordance with Section 3-10 of Regulation S-X of the Securities Act, the following condensed consolidating financial statements are provided prospectively to present the statement of comprehensive income (loss), financial position and cash flows of:
	(1) Truven Holding Corp., the Parent;
	(2) Truven Health Analytics, Inc., the Subsidiary Issuer;
	(3) Simpler North America LLC, Simpler Consulting LLC, JWA, and HBE, the Guarantor subsidiaries;
	(4) All foreign non-Guarantor subsidiaries; and
	(5) eliminations to arrive at the information for Truven Holding Corp. on a consolidated basis.
	Separate financial statements and other disclosures concerning the Guarantors are not presented because management does not believe such information is material.
	Truven Holding Corp.
	Unaudited Interim Condensed Consolidated Balance Sheets
	As of March 31, 2015
		Parent			Issuer			Guarantor subsidiaries			Non-Guarantor subsidiaries			Eliminations			Consolidated
	Assets
	Cash and cash equivalents	$	—		$	22,494		$	3,957		$	1,836		$	—		$	28,287
	Trade and other receivables, net of allowances	—			89,249			13,032			1,390			—			103,671
	Prepaid expenses and other current assets	—			26,261			1,026			933			—			28,220
	Deferred tax asset	—			443			—			—			—			443
	Intercompany receivable	—			26,815			41,716			48,758			(117,289		)	—
	Total current assets	—			165,262			59,731			52,917			(117,289		)	160,621
	Investment in subsidiaries	15,602			106,863			(78		)	—			(122,387		)	—
	Computer hardware and other property, net	—			33,145			178			712			—			34,035
	Developed technology and content, net	—			123,386			6,110			—			—			129,496
	Goodwill	—			457,677			41,143			—			—			498,820
	Other identifiable intangible assets, net	—			318,939			50,915			—			—			369,854
	Other noncurrent assets	—			15,355			—			14			—			15,369
	Total assets	$	15,602		$	1,220,627		$	157,999		$	53,643		$	(239,676	)	$	1,208,195
	Liabilities and Net Equity
	Accounts payable and accrued expenses	$	—		$	58,834		$	7,003		$	2,631		$	—		$	68,468
	Deferred revenue	—			126,418			8,361			318			—			135,097
	Current portion of long-term debt	—			6,360			—			—			—			6,360
	Capital lease obligation	—			673			—			—			—			673
	Deferred tax liability	—			—			—			—			—			—
	Current taxes payable	—			—			32			11			—			43
	Intercompany payable	—			30,915			37,132			49,242			(117,289		)	—
	Total current liabilities	—			223,200			52,528			52,202			(117,289		)	210,641
	Deferred revenue	—			6,179			127			—			—			6,306
	Capital lease obligation - noncurrent	—			1,203			—			—			—			1,203
	Long-term debt	—			970,580			—			—			—			970,580
	Deferred tax liabilities	—			443			—			—			—			443
	Other noncurrent liabilities	—			3,420			—			—			—			3,420
	Total liabilities	—			1,205,025			52,655			52,202			(117,289		)	1,192,593
	Equity
	Common stock	—			—			—			—			—			—
	Additional paid-in capital	483,861			483,861			114,090			(125		)	(597,826		)	483,861
	Accumulated deficit	(468,133		)	(468,133		)	(8,782		)	1,871			475,044			(468,133		)
	Foreign currency translation adjustment	(126		)	(126		)	36			(305		)	395			(126		)
	Total	15,602			15,602			105,344			1,441			(122,387		)	15,602
	Total liabilities and net equity	$	15,602		$	1,220,627		$	157,999		$	53,643		$	(239,676	)	$	1,208,195
	Truven Holding Corp.
	Consolidated Balance Sheets
	As of December 31, 2014
		Parent			Issuer			Guarantor subsidiaries			Non-Guarantor subsidiaries			Eliminations			Consolidated
	Assets
	Cash and cash equivalents	$	—		$	8,243		$	3,264		$	1,097		$	—		$	12,604
	Trade and other receivables, net of allowances	—			106,181			12,765			1,268			—			120,214
	Prepaid expenses and other current assets	—			28,574			817			860			—			30,251
	Deferred tax asset	—			621			—			—			—			621
Intercompany receivable	—			23,297			39,194			46,799			(109,290		)	—
Total current assets	—			166,916			56,040			50,024			(109,290		)	163,690
Investment in subsidiaries	47,123			109,851			(192		)	—			(156,782		)	—
Computer hardware and other property, net	—			36,459			207			769			—			37,435
Developed technology and content, net	—			128,917			5,161			—			—			134,078
Goodwill	—			457,677			41,143			—			—			498,820
Other identifiable intangible assets, net	—			327,554			55,325			—			—			382,879
Other noncurrent assets	—			15,951			—			236			—			16,187
Total assets	$	47,123		$	1,243,325		$	157,684		$	51,029		$	(266,072	)	$	1,233,089
Liabilities and Net Equity
Accounts payable and accrued expenses	$	—		$	58,777		$	5,931		$	2,520		$	—		$	67,228
Deferred revenue	—			121,903			6,802			424			—			129,129
Current portion of long-term debt	—			6,360			—			—			—			6,360
Capital lease obligation	—			664			—			—			—			664
Deferred tax liability	—			—			—			—			—			—
Current taxes payable	—			—			—			173			—			173
Intercompany payable	—			26,086			35,784			47,420			(109,290		)	—
Total current liabilities	—			213,790			48,517			50,537			(109,290		)	203,554
Deferred revenue	—			5,456			—			—			—			5,456
Capital lease obligation - noncurrent	—			1,374			—			—			—			1,374
Long-term debt	—			971,362			—			—			—			971,362
Deferred tax liabilities	—			621			—			—			—			621
Other noncurrent liabilities	—			3,599			—			—			—			3,599
Total liabilities	—			1,196,202			48,517			50,537			(109,290		)	1,185,966
Equity
Common stock	—			—			—			—			—			—
Additional paid-in capital	483,550			483,550			114,483			(125		)	(597,908		)	483,550
Accumulated deficit	(436,123		)	(436,123		)	(5,275		)	1,130			440,268			(436,123		)
Foreign currency translation adjustment	(304		)	(304		)	(41		)	(513		)	858			(304		)
Total	47,123			47,123			109,167			492			(156,782		)	47,123
Total liabilities and net equity	$	47,123		$	1,243,325		$	157,684		$	51,029		$	(266,072	)	$	1,233,089
Truven Holding Corp.
Unaudited Interim Condensed Consolidated Statements of Comprehensive Loss
For the Three Months Ended March 31, 2015
	Parent			Issuer			Guarantor subsidiaries			Non-Guarantor subsidiaries			Eliminations			Consolidated
Revenues, net	$	—		$	123,304		$	16,663		$	5,938		$	(2,732	)	$	143,173
Operating costs and expenses	—			(74,939		)	(9,474		)	(1,807		)	2,391			(83,829		)
Cost of revenues, excluding depreciation and amortization
Selling and marketing, excluding depreciation and amortization	—			(12,720		)	(1,472		)	(1,742		)	—			(15,934		)
General and administrative, excluding depreciation and amortization	—			(11,372		)	(4,255		)	(1,255		)	—			(16,882		)
Depreciation	—			(5,006		)	(29		)	(100		)	—			(5,135		)
Amortization of developed technology and content	—			(10,563		)	(246		)	—			—			(10,809		)
Amortization of other identifiable intangible assets	—			(8,615		)	(4,410		)	—			—			(13,025		)
Other operating expenses	—			(10,588		)	(91		)	—			341			(10,338		)
Total operating costs and expenses	—			(133,803		)	(19,977		)	(4,904		)	2,732			(155,952		)
Operating income (loss)	—			(10,499		)	(3,314		)	1,034			—			(12,779		)
Net interest expense	—			(18,469		)	1			(4		)	—			(18,472		)
Other finance costs	—			(270		)	(116		)	(83		)	—			(469		)
Equity in net income (loss) of subsidiaries	(32,010		)	(2,772		)	6			—			34,776			—
Income (loss) before income taxes	(32,010		)	(32,010		)	(3,423		)	947			34,776			(31,720		)
Provision for income taxes	—			—			(84		)	(206		)	—			(290		)
Net income (loss)	$	(32,010	)	$	(32,010	)	$	(3,507	)	$	741		$	34,776		$	(32,010	)
Other comprehensive income (loss):
Foreign currency translation adjustments	178			178			77			208			(463		)	178
Total comprehensive income (loss)	$	(31,832	)	$	(31,832	)	$	(3,430	)	$	949		$	34,313		$	(31,832	)
	Parent			Issuer			Guarantor subsidiaries			Non-Guarantor subsidiaries			Eliminations			Consolidated
Operating activities
Net income (loss)	$	(32,010	)	$	(32,010	)	$	(3,507	)	$	741		$	34,776		$	(32,010	)
Non-cash adjustments	32,010			34,809			4,679			100			(34,776		)	36,822
Changes in operating assets and liabilities	—			23,101			1,921			(130		)	—			24,892
Net cash provided by operating activities	—			25,900			3,093			711			—			29,704
Investing activities
Acquisition - payment of working capital adjustment	—			(91		)	—			—			—			(91		)
Capital expenditures	—			(11,116		)	(1,196		)	(43		)	—			(12,355		)
Net cash used in investing activities	—			(11,207		)	(1,196		)	(43		)	—			(12,446		)
Financing activities
Intercompany transaction	—			1,311			(1,174		)	(137		)	—			—
Principal repayment of senior term loan	—			(1,590		)	—			—			—			(1,590		)
Payment of capital lease obligation	—			(163		)	—			—			—			(163		)
Net cash used in financing activities	—			(442		)	(1,174		)	(137		)	—			(1,753		)
Effect of exchange rate changes in cash and cash equivalents	—			—			(30		)	208			—			178
Increase in cash and cash equivalents	—			14,251			693			739			—			15,683
Cash and cash equivalents
Beginning of period	—			8,243			3,264			1,097			—			12,604
End of period	$	—		$	22,494		$	3,957		$	1,836		$	—		$	28,287

Description_of_Business_and_Ba1

Description of Business and Basis of Presentation (Policies)	3 Months Ended
	Mar. 31, 2015
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	Basis of Presentation
	These unaudited interim condensed consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim reporting and are consistent with the accounting policies and methods used in preparation of the Company's consolidated financial statements as of December 31, 2014. The preparation of interim condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the interim condensed consolidated financial statements and accompanying notes. Although these estimates are based on management's knowledge of current events and actions that the Company may undertake in the future, actual results could differ from those estimates. Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted. In the opinion of management, all adjustments (consisting only of normal and recurring adjustments) necessary for a fair statement for the periods presented have been recorded. The results of operations for the three months ended March 31, 2015, are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2015. These financial statements should be read in conjunction with, and have been prepared in conformity with, the accounting principles reflected in the Company’s financial statements and the notes thereto for the year ended December 31, 2014 included in the Form10-K as filed with the Securities and Exchange Commission ("SEC") on March 13, 2015.
Segment Information	Segment Information
	The determination of reportable segments was based on the discrete financial information provided to the Chief Operating Decision Maker (the "CODM"). The Chief Executive Officer has the authority for resource allocation and assessment of the Company’s performance and is, therefore, the CODM. The Company’s segment structure enables us to more effectively focus on business and market facing opportunities and to simplify our business decision-making process. The Company's reportable segments are as follows:
	Commercial
	The Commercial segment provides analytic solutions and services to improve the cost, quality, and effectiveness of healthcare for commercial organizations across the healthcare industry including providers, integrated delivery networks, insurers, professional services organizations, healthcare exchanges and employers.
	Government
	The Government segment provides integrated analytic solutions and services to improve the cost, quality, and effectiveness of healthcare for federal and state agencies (e.g. Centers for Medicare & Medicaid Services and state Medicaid agencies) and federally owned and operated healthcare facilities.  Our sales and client services are tailored to meet the specific procurement, sales and support requirements of the government market.
	The CODM evaluates the performance of our segments based on segment operating income (loss), which is calculated internally as net sales, less cost of operations (including allocation of technology costs), selling and marketing, and general and administrative expenses, excluding depreciation and amortization.
	Center/shared services consist of items that are not directly attributable to reportable segments, such as corporate administrative costs and elimination of intercompany transactions.
	Corporate expenses may include other non-recurring or non-operational activity that the CODM excludes in assessing operating segment performance. These expenses, along with depreciation and amortization, other operating income/expense and other non-operating activity such as interest expense/income, are not considered in the measure of the segments’ operating performance, but are shown herein as reconciling items to the Company’s consolidated loss before income taxes.
	The accounting policies for the reportable segments are the same as those for the consolidated Company. The Company’s operations and customers are based primarily in the United States.
Income Taxes	Income Taxes
	Income tax provisions for interim periods are based on estimated annual income tax rates, adjusted to reflect the effects of any significant infrequent or unusual items which are required to be discretely recognized within the current interim period. The Company’s intention is to permanently reinvest its foreign earnings outside of the United States. As a result, the effective tax rates in the periods presented are largely based upon the projected annual pre-tax earnings by jurisdiction and the allocation of certain expenses in various taxing jurisdictions where the Company conducts its business. These taxing jurisdictions apply a broad range of statutory income tax rates.

Acquisitions_Tables

Acquisitions (Tables)	3 Months Ended
	Mar. 31, 2015
Simpler
Business Acquisition [Line Items]
Schedule of Assets and Liabilities Acquired	The allocation of the purchase price is based on management's judgment after evaluating several factors, including a valuation assessment prepared by a third party valuation firm:
		Values recognized at acquisition date
	Trade and other receivables	$	7,560
	Prepaid assets and other current assets	425
	Computer hardware and other property	181
	Other identifiable intangible assets	47,500
	Current liabilities	(2,575		)
	Deferred revenue	(600		)
	Net assets acquired	52,491
	Goodwill on acquisition	28,571
	Net consideration	$	81,062
Business Acquisition, Pro Forma Information	The following unaudited pro forma financial data summarizes the Simpler’s results of operations for the three months ended March 31, 2014 had the acquisition of Simpler occurred as of January 1, 2013:
			Three months ended March 31, 2014
			(Unaudited)
	Revenues, net		$	12,663
	Net loss		1,217
JWA
Business Acquisition [Line Items]
Schedule of Assets and Liabilities Acquired
		Values recognized at acquisition date
	Trade and other receivables	$	1,462
	Prepaid assets and other current assets	41
	Computer hardware and other property	17
	Other identifiable intangible assets	7,489
	Current liabilities	(607		)
	Deferred revenue	(126		)
	Net assets acquired	8,276
	Goodwill on acquisition	7,020
	Net consideration	$	15,296
Business Acquisition, Pro Forma Information	The following unaudited pro forma financial data summarizes JWA's results of operations for the three months ended March 31, 2014 had the acquisition of JWA occurred as of January 1, 2013:
				Three months ended March 31, 2014
				(Unaudited)
	Revenues, net			$	2,831
	Net Income			173
HBE
Business Acquisition [Line Items]
Schedule of Assets and Liabilities Acquired	The following is a summary of the allocation of the purchase price of the HBE Transaction to the estimated fair values of assets acquired and liabilities assumed in the HBE Transaction. The allocation of the purchase price is based on management's judgment after evaluating several factors, including a valuation assessment prepared by a third party valuation firm:
		Values recognized at acquisition date
	Trade and other receivables	$	7,670
	Prepaid assets and other current assets	768
	Computer hardware and other property	140
	Developed technology and content	4,621
	Other identifiable intangible assets	11,278
	Other noncurrent assets	67
	Current liabilities	(8,604		)
	Deferred revenue	(4,249		)
	Net assets acquired	11,691
	Goodwill on acquisition	5,552
	Net consideration	$	17,243
Business Acquisition, Pro Forma Information	The following unaudited pro forma financial data summarizes HBE’s results of operations for the three months ended March 31, 2014 had the acquisition of HBE occurred as of January 1, 2013:
			Three months ended March 31, 2014
			(Unaudited)
	Revenues, net		$	5,444
	Net income		992

Goodwill_Tables

Goodwill (Tables)	3 Months Ended
	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	The changes in the carrying amount of goodwill by reportable segment during the three months ended March 31, 2015, were as follows:
		Commercial			Government			Total
	Balance as of March 31, 2015 and December 31, 2014	$	774,184		$	91,298		$	865,482
	Accumulated impairment:
	Balance as of March 31, 2015 and December 31, 2014	(321,064		)	(45,598		)	(366,662		)
	Net book value as of March 31, 2015 and December 31, 2014	$	453,120		$	45,700		$	498,820

Other_Identifiable_Intangible_1

Other Identifiable Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2015
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	Other identifiable intangible assets, net, consisted of the following:
		As of March 31, 2015
		Average life (years)	Cost		Accumulated amortization			Net
	Customer relationships	11	$	366,085	$	(83,953	)	$	282,132
	Trademarks and trade names	15	97,024		(16,884		)	80,140
	Backlog	1	14,732		(9,886		)	4,846
	Non-Compete	3	4,426		(1,690		)	2,736
			$	482,267	$	(112,413	)	$	369,854
		As of December 31, 2014
		Average life (years)	Cost		Accumulated amortization			Net
	Customer relationships	11	$	366,085	$	(75,756	)	$	290,329
	Trademarks and trade names	15	97,024		(15,224		)	81,800
	Backlog	1	14,732		(7,160		)	7,572
	Non-Compete	3	4,426		(1,248		)	3,178
			$	482,267	$	(99,388	)	$	382,879

Longterm_Debt_Tables

Long-term Debt (Tables)	3 Months Ended
	Mar. 31, 2015
Debt Disclosure [Abstract]
Schedule of Long-term Debt Instruments	The Company's long-term debt consists of the following:
			March 31, 2015		December 31, 2014
	Senior Credit Facility
		Term Loan Facility (net of $13,239 and $14,035 discount, respectively)	$	610,051	$	610,845
	10.625% Senior Notes ("the Notes") (net of $1,388 and $1,455 discount, respectively)		325,762		325,695
	10.625% Additional Senior Notes ("the Additional Notes") (including $1,127 and $1,182 premium, respectively)		41,127		41,182
			976,940		977,722
	Less: current portion of long-term debt		6,360		6,360
	Long-term debt		$	970,580	$	971,362
Schedule of Principal Maturities of Long-term Debt	As of March 31, 2015, principal maturities of long-term debt for the next five years and thereafter consist of:
	For the period ending March 31,
	2016	$	6,360
	2017	6,360
	2018	6,360
	2019	6,360
	2020	584,611
	Thereafter	366,889
		$	976,940

Other_Operating_Expenses_Table

Other Operating Expenses (Tables)	3 Months Ended
	Mar. 31, 2015
Other Income and Expenses [Abstract]
Components of other operating expenses	The components of other operating expenses include the following:
		Three months ended March 31,
		2015		2014
	Severance and retention bonuses	$	578	$	562
	Acquisition-related costs and other non-recurring charges	2,779		620
	Asset Write-off (see Note 12)	6,000		4,706
	Sponsor fee (see Note 10)	981		641
	Total other operating expenses	$	10,338	$	6,529

Segment_Information_Tables

Segment Information (Tables)	3 Months Ended
	Mar. 31, 2015
Segment Reporting [Abstract]
Schedule of Segment Reporting Information	Segment information for the three months ended March 31, 2015 and 2014 is as follows:
		Three months ended March 31,
		2015						2014
		Revenue			Segment operating income			Revenue		Segment operating income
	Commercial	$	118,380		$	35,536		$	96,350	$	29,957
	Government	25,135			(1,277		)	21,912		(641		)
	Segment totals	143,515			34,259			118,262		29,316
	Center/Shared services	(341		)	(7,731		)	—		(6,350		)
	Segment operating income	$	143,174		$	26,528		$	118,262	$	22,966
	Segment operating Margin				19		%			19		%
Reconciliation of Operating Profit (Loss) from Segments to Consolidated	The following table reconciles unaudited condensed segment operating income per the reportable segment information to loss before income taxes per the unaudited interim condensed consolidated statements of comprehensive loss.
		Three months ended March 31,
		2015			2014
	Segment operating income	$	26,528		$	22,966
	Depreciation	(5,135		)	-6,593
	Amortization of developed technology and content	(10,809		)	-9,197
	Amortization of other identifiable intangible assets	(13,025		)	-8,615
	Other operating expenses	(10,338		)	(6,529		)
	Operating income	(12,779		)	(7,968		)
	Net interest expense	(18,472		)	(16,273		)
	Other finance costs	(469		)	(76		)
	Loss before income taxes	$	(31,720	)	$	(24,317	)

Sharebased_Compensation_Tables

Share-based Compensation (Tables)	3 Months Ended
	Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Transaction Related to Class B membership Interest	A summary of the Membership Interests is as follows:
		Class B			Class B-1
		Ownership interest (%)	Fair value at grant date		Ownership interest (%)	Fair value at grant date
	Total outstanding balance at December 31, 2014 and March 31, 2015	4.4	$	6,100	0.9	$	1,067
	Total vested as of March 31, 2015	1.7	$	2,391	—	$	—

Fair_Value_Measurement_Tables

Fair Value Measurement (Tables)	3 Months Ended
	Mar. 31, 2015
Fair Value Disclosures [Abstract]
Carrying amounts and fair values of the Term Loan Facility	At March 31, 2015, the carrying amounts and fair values of the Senior Credit Facility and 10.625% Senior Notes were as follows:
			Fair values
		Carrying amounts	Level 1		Level 2		Level 3
	Senior Term Loan	610,051	$	—	$	625,596	$	—
	10.625% Senior Notes	366,889	—		386,425		—
	At December 31, 2014, the carrying amounts and fair values of the Senior Credit facility and 10.625% Senior Notes were as follows:
			Fair values
		Carrying amounts	Level 1		Level 2		Level 3
	Senior Term Loan	610,845	$	—	$	603,009	$	—
	10.625% Senior Notes	366,877	—		357,971		—

Supplemental_Guarantor_Financi1

Supplemental Guarantor Financial Information (Tables)	3 Months Ended
	Mar. 31, 2015
Condensed Financial Information of Parent Company Only Disclosure [Abstract]
Unaudited Interim Condensed Consolidated Balance Sheets	Truven Holding Corp.
	Unaudited Interim Condensed Consolidated Balance Sheets
	As of March 31, 2015
		Parent			Issuer			Guarantor subsidiaries			Non-Guarantor subsidiaries			Eliminations			Consolidated
	Assets
	Cash and cash equivalents	$	—		$	22,494		$	3,957		$	1,836		$	—		$	28,287
	Trade and other receivables, net of allowances	—			89,249			13,032			1,390			—			103,671
	Prepaid expenses and other current assets	—			26,261			1,026			933			—			28,220
	Deferred tax asset	—			443			—			—			—			443
	Intercompany receivable	—			26,815			41,716			48,758			(117,289		)	—
	Total current assets	—			165,262			59,731			52,917			(117,289		)	160,621
	Investment in subsidiaries	15,602			106,863			(78		)	—			(122,387		)	—
	Computer hardware and other property, net	—			33,145			178			712			—			34,035
	Developed technology and content, net	—			123,386			6,110			—			—			129,496
	Goodwill	—			457,677			41,143			—			—			498,820
	Other identifiable intangible assets, net	—			318,939			50,915			—			—			369,854
	Other noncurrent assets	—			15,355			—			14			—			15,369
	Total assets	$	15,602		$	1,220,627		$	157,999		$	53,643		$	(239,676	)	$	1,208,195
	Liabilities and Net Equity
	Accounts payable and accrued expenses	$	—		$	58,834		$	7,003		$	2,631		$	—		$	68,468
	Deferred revenue	—			126,418			8,361			318			—			135,097
	Current portion of long-term debt	—			6,360			—			—			—			6,360
	Capital lease obligation	—			673			—			—			—			673
	Deferred tax liability	—			—			—			—			—			—
	Current taxes payable	—			—			32			11			—			43
	Intercompany payable	—			30,915			37,132			49,242			(117,289		)	—
	Total current liabilities	—			223,200			52,528			52,202			(117,289		)	210,641
	Deferred revenue	—			6,179			127			—			—			6,306
	Capital lease obligation - noncurrent	—			1,203			—			—			—			1,203
	Long-term debt	—			970,580			—			—			—			970,580
	Deferred tax liabilities	—			443			—			—			—			443
	Other noncurrent liabilities	—			3,420			—			—			—			3,420
	Total liabilities	—			1,205,025			52,655			52,202			(117,289		)	1,192,593
	Equity
	Common stock	—			—			—			—			—			—
	Additional paid-in capital	483,861			483,861			114,090			(125		)	(597,826		)	483,861
	Accumulated deficit	(468,133		)	(468,133		)	(8,782		)	1,871			475,044			(468,133		)
	Foreign currency translation adjustment	(126		)	(126		)	36			(305		)	395			(126		)
	Total	15,602			15,602			105,344			1,441			(122,387		)	15,602
	Total liabilities and net equity	$	15,602		$	1,220,627		$	157,999		$	53,643		$	(239,676	)	$	1,208,195
	Truven Holding Corp.
	Consolidated Balance Sheets
	As of December 31, 2014
		Parent			Issuer			Guarantor subsidiaries			Non-Guarantor subsidiaries			Eliminations			Consolidated
	Assets
	Cash and cash equivalents	$	—		$	8,243		$	3,264		$	1,097		$	—		$	12,604
	Trade and other receivables, net of allowances	—			106,181			12,765			1,268			—			120,214
	Prepaid expenses and other current assets	—			28,574			817			860			—			30,251
	Deferred tax asset	—			621			—			—			—			621
	Intercompany receivable	—			23,297			39,194			46,799			(109,290		)	—
	Total current assets	—			166,916			56,040			50,024			(109,290		)	163,690
	Investment in subsidiaries	47,123			109,851			(192		)	—			(156,782		)	—
	Computer hardware and other property, net	—			36,459			207			769			—			37,435
	Developed technology and content, net	—			128,917			5,161			—			—			134,078
	Goodwill	—			457,677			41,143			—			—			498,820
	Other identifiable intangible assets, net	—			327,554			55,325			—			—			382,879
	Other noncurrent assets	—			15,951			—			236			—			16,187
	Total assets	$	47,123		$	1,243,325		$	157,684		$	51,029		$	(266,072	)	$	1,233,089
	Liabilities and Net Equity
	Accounts payable and accrued expenses	$	—		$	58,777		$	5,931		$	2,520		$	—		$	67,228
	Deferred revenue	—			121,903			6,802			424			—			129,129
	Current portion of long-term debt	—			6,360			—			—			—			6,360
	Capital lease obligation	—			664			—			—			—			664
	Deferred tax liability	—			—			—			—			—			—
Current taxes payable	—			—			—			173			—			173
Intercompany payable	—			26,086			35,784			47,420			(109,290		)	—
Total current liabilities	—			213,790			48,517			50,537			(109,290		)	203,554
Deferred revenue	—			5,456			—			—			—			5,456
Capital lease obligation - noncurrent	—			1,374			—			—			—			1,374
Long-term debt	—			971,362			—			—			—			971,362
Deferred tax liabilities	—			621			—			—			—			621
Other noncurrent liabilities	—			3,599			—			—			—			3,599
Total liabilities	—			1,196,202			48,517			50,537			(109,290		)	1,185,966
Equity
Common stock	—			—			—			—			—			—
Additional paid-in capital	483,550			483,550			114,483			(125		)	(597,908		)	483,550
Accumulated deficit	(436,123		)	(436,123		)	(5,275		)	1,130			440,268			(436,123		)
Foreign currency translation adjustment	(304		)	(304		)	(41		)	(513		)	858			(304		)
Total	47,123			47,123			109,167			492			(156,782		)	47,123
Total liabilities and net equity	$	47,123		$	1,243,325		$	157,684		$	51,029		$	(266,072	)	$	1,233,089
Unaudited Interim Condensed Consolidated Statements of Comprehensive Loss	Truven Holding Corp.
	Unaudited Interim Condensed Consolidated Statements of Comprehensive Loss
	For the Three Months Ended March 31, 2015
		Parent			Issuer			Guarantor subsidiaries			Non-Guarantor subsidiaries			Eliminations			Consolidated
	Revenues, net	$	—		$	123,304		$	16,663		$	5,938		$	(2,732	)	$	143,173
	Operating costs and expenses	—			(74,939		)	(9,474		)	(1,807		)	2,391			(83,829		)
	Cost of revenues, excluding depreciation and amortization
	Selling and marketing, excluding depreciation and amortization	—			(12,720		)	(1,472		)	(1,742		)	—			(15,934		)
	General and administrative, excluding depreciation and amortization	—			(11,372		)	(4,255		)	(1,255		)	—			(16,882		)
	Depreciation	—			(5,006		)	(29		)	(100		)	—			(5,135		)
	Amortization of developed technology and content	—			(10,563		)	(246		)	—			—			(10,809		)
	Amortization of other identifiable intangible assets	—			(8,615		)	(4,410		)	—			—			(13,025		)
	Other operating expenses	—			(10,588		)	(91		)	—			341			(10,338		)
	Total operating costs and expenses	—			(133,803		)	(19,977		)	(4,904		)	2,732			(155,952		)
	Operating income (loss)	—			(10,499		)	(3,314		)	1,034			—			(12,779		)
	Net interest expense	—			(18,469		)	1			(4		)	—			(18,472		)
	Other finance costs	—			(270		)	(116		)	(83		)	—			(469		)
	Equity in net income (loss) of subsidiaries	(32,010		)	(2,772		)	6			—			34,776			—
	Income (loss) before income taxes	(32,010		)	(32,010		)	(3,423		)	947			34,776			(31,720		)
	Provision for income taxes	—			—			(84		)	(206		)	—			(290		)
	Net income (loss)	$	(32,010	)	$	(32,010	)	$	(3,507	)	$	741		$	34,776		$	(32,010	)
	Other comprehensive income (loss):
	Foreign currency translation adjustments	178			178			77			208			(463		)	178
	Total comprehensive income (loss)	$	(31,832	)	$	(31,832	)	$	(3,430	)	$	949		$	34,313		$	(31,832	)
Unaudited Condensed Consolidated Statements of Cash Flows
		Parent			Issuer			Guarantor subsidiaries			Non-Guarantor subsidiaries			Eliminations			Consolidated
	Operating activities
	Net income (loss)	$	(32,010	)	$	(32,010	)	$	(3,507	)	$	741		$	34,776		$	(32,010	)
	Non-cash adjustments	32,010			34,809			4,679			100			(34,776		)	36,822
	Changes in operating assets and liabilities	—			23,101			1,921			(130		)	—			24,892
	Net cash provided by operating activities	—			25,900			3,093			711			—			29,704
	Investing activities
	Acquisition - payment of working capital adjustment	—			(91		)	—			—			—			(91		)
	Capital expenditures	—			(11,116		)	(1,196		)	(43		)	—			(12,355		)
	Net cash used in investing activities	—			(11,207		)	(1,196		)	(43		)	—			(12,446		)
	Financing activities
	Intercompany transaction	—			1,311			(1,174		)	(137		)	—			—
	Principal repayment of senior term loan	—			(1,590		)	—			—			—			(1,590		)
	Payment of capital lease obligation	—			(163		)	—			—			—			(163		)
	Net cash used in financing activities	—			(442		)	(1,174		)	(137		)	—			(1,753		)
	Effect of exchange rate changes in cash and cash equivalents	—			—			(30		)	208			—			178
	Increase in cash and cash equivalents	—			14,251			693			739			—			15,683
	Cash and cash equivalents
	Beginning of period	—			8,243			3,264			1,097			—			12,604
	End of period	$	—		$	22,494		$	3,957		$	1,836		$	—		$	28,287

Description_of_Business_and_Ba2

Description of Business and Basis of Presentation (Details)	3 Months Ended
	Mar. 31, 2015
	Segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of reportable segments	2

Acquisitions_Narrative_Details

Acquisitions - Narrative (Details) (USD $)	0 Months Ended	3 Months Ended	0 Months Ended
	Apr. 11, 2014	Mar. 31, 2015	Oct. 31, 2014	Nov. 12, 2014
			annual_payment
Simpler
Business Acquisition [Line Items]
Payments for acquisition	$81,100,000
Working capital adjustment	1,100,000
Equity issued	3,700,000
Acquisition related costs	3,600,000
Intangible assets acquired	47,500,000
Revenues		13,800,000
Net loss		1,500,000
Simpler | Trademarks and trade names
Business Acquisition [Line Items]
Intangible assets acquired	8,000,000
Useful life of intangible assets acquired	13 years
Simpler | Customer relationships
Business Acquisition [Line Items]
Intangible assets acquired	21,400,000
Simpler | Customer relationships | Minimum
Business Acquisition [Line Items]
Useful life of intangible assets acquired	3 years
Simpler | Customer relationships | Maximum
Business Acquisition [Line Items]
Useful life of intangible assets acquired	9 years
Simpler | Backlogs
Business Acquisition [Line Items]
Intangible assets acquired	13,700,000
Simpler | Backlogs | Minimum
Business Acquisition [Line Items]
Useful life of intangible assets acquired	1 year
Simpler | Backlogs | Maximum
Business Acquisition [Line Items]
Useful life of intangible assets acquired	2 years
Simpler | Non-compete agreements
Business Acquisition [Line Items]
Intangible assets acquired	4,400,000
Simpler | Non-compete agreements | Minimum
Business Acquisition [Line Items]
Useful life of intangible assets acquired	2 years
Simpler | Non-compete agreements | Maximum
Business Acquisition [Line Items]
Useful life of intangible assets acquired	3 years
JWA
Business Acquisition [Line Items]
Payments for acquisition			15,300,000
Working capital adjustment			1,200,000
Acquisition related costs			600,000
Intangible assets acquired			7,489,000
Revenues		3,100,000
Net loss		200,000
Holdback payment payable			100,000
Annual payments to former shareholder			1,900,000
Number of annual payments to former shareholder			3
JWA | Trademarks and trade names
Business Acquisition [Line Items]
Intangible assets acquired			300,000
JWA | Trademarks and trade names | Minimum
Business Acquisition [Line Items]
Useful life of intangible assets acquired			3 years
JWA | Trademarks and trade names | Maximum
Business Acquisition [Line Items]
Useful life of intangible assets acquired			5 years
JWA | Customer relationships
Business Acquisition [Line Items]
Intangible assets acquired			6,100,000
JWA | Customer relationships | Minimum
Business Acquisition [Line Items]
Useful life of intangible assets acquired			10 years
JWA | Customer relationships | Maximum
Business Acquisition [Line Items]
Useful life of intangible assets acquired			11 years
JWA | Backlogs
Business Acquisition [Line Items]
Intangible assets acquired			1,000,000
Useful life of intangible assets acquired			1 year
HBE
Business Acquisition [Line Items]
Payments for acquisition				17,200,000
Working capital adjustment				2,800,000
Acquisition related costs				1,200,000
Intangible assets acquired				11,278,000
Revenues		2,800,000
Net loss		1,800,000
Adjustment impact on current assets		-300,000
Adjustment impact on total liabilities		100,000
HBE | Trademarks and trade names
Business Acquisition [Line Items]
Intangible assets acquired				2,500,000
HBE | Trademarks and trade names | Minimum
Business Acquisition [Line Items]
Useful life of intangible assets acquired				12 years
HBE | Trademarks and trade names | Maximum
Business Acquisition [Line Items]
Useful life of intangible assets acquired				14 years
HBE | Customer relationships
Business Acquisition [Line Items]
Intangible assets acquired				$8,800,000
HBE | Customer relationships | Minimum
Business Acquisition [Line Items]
Useful life of intangible assets acquired				9 years
HBE | Customer relationships | Maximum
Business Acquisition [Line Items]
Useful life of intangible assets acquired				11 years

Acquisitions_Assets_and_Liabil

Acquisitions - Assets and Liabilities Acquired (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Apr. 11, 2014	Oct. 31, 2014	Nov. 12, 2014
In Thousands, unless otherwise specified
Business Acquisition [Line Items]
Goodwill on acquisition	$498,820	$498,820
Simpler
Business Acquisition [Line Items]
Trade and other receivables			7,560
Prepaid assets and other current assets			425
Computer hardware and other property			181
Other identifiable intangible assets			47,500
Current liabilities			-2,575
Deferred revenue			-600
Net assets acquired			52,491
Goodwill on acquisition			28,571
Net consideration			81,062
JWA
Business Acquisition [Line Items]
Trade and other receivables				1,462
Prepaid assets and other current assets				41
Computer hardware and other property				17
Other identifiable intangible assets				7,489
Current liabilities				-607
Deferred revenue				-126
Net assets acquired				8,276
Goodwill on acquisition				7,020
Net consideration				15,296
HBE
Business Acquisition [Line Items]
Trade and other receivables					7,670
Prepaid assets and other current assets					768
Computer hardware and other property					140
Developed technology and content					4,621
Other identifiable intangible assets					11,278
Other noncurrent assets					67
Current liabilities					-8,604
Deferred revenue					-4,249
Net assets acquired					11,691
Goodwill on acquisition					5,552
Net consideration					$17,243

Acquisitions_Pro_Forma_Informa

Acquisitions - Pro Forma Information (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2014
HBE
Business Acquisition [Line Items]
Revenues, net	$5,444
Net income (loss)	992
JWA
Business Acquisition [Line Items]
Revenues, net	2,831
Net income (loss)	173
Simpler
Business Acquisition [Line Items]
Revenues, net	12,663
Net income (loss)	$1,217

Goodwill_Details

Goodwill (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Goodwill [Roll Forward]
Gross goodwill	$865,482	$865,482
Accumulated impairment	-366,662	-366,662
Net goodwill	498,820	498,820
Commercial
Goodwill [Roll Forward]
Gross goodwill	774,184	774,184
Accumulated impairment	-321,064	-321,064
Net goodwill	453,120	453,120
Government
Goodwill [Roll Forward]
Gross goodwill	91,298	91,298
Accumulated impairment	-45,598	-45,598
Net goodwill	$45,700	$45,700

Other_Identifiable_Intangible_2

Other Identifiable Intangible Assets (Details) (USD $)	3 Months Ended	12 Months Ended
	Mar. 31, 2015	Dec. 31, 2014
Finite-Lived Intangible Assets [Line Items]
Cost	$482,267,000	$482,267,000
Accumulated amortization	-112,413,000	-99,388,000
Net	369,854,000	382,879,000
Finite-Lived Intangible Assets, Net, Amortization Expense, Rolling Maturity [Abstract]
12 Months ending September 30, 2016	46,000,000
12 Months ending September 30, 2017	40,400,000
12 Months ending September 30, 2018	39,400,000
12 Months ending September 30, 2019	39,000,000
12 Months ending September 30, 2020	38,900,000
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Average life (years)	11 years	11 years
Cost	366,085,000	366,085,000
Accumulated amortization	-83,953,000	-75,756,000
Net	282,132,000	290,329,000
Trademarks and trade names
Finite-Lived Intangible Assets [Line Items]
Average life (years)	15 years	15 years
Cost	97,024,000	97,024,000
Accumulated amortization	-16,884,000	-15,224,000
Net	80,140,000	81,800,000
Backlogs
Finite-Lived Intangible Assets [Line Items]
Average life (years)	1 year	1 year
Cost	14,732,000	14,732,000
Accumulated amortization	-9,886,000	-7,160,000
Net	4,846,000	7,572,000
Non-Compete
Finite-Lived Intangible Assets [Line Items]
Average life (years)	3 years	3 years
Cost	4,426,000	4,426,000
Accumulated amortization	-1,690,000	-1,248,000
Net	$2,736,000	$3,178,000

Longterm_Debt_Schedule_of_Long

Long-term Debt - Schedule of Long-term Debt (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Jun. 06, 2012
In Thousands, unless otherwise specified
Debt Instrument [Line Items]
Long-term debt	$976,940	$977,722
Current portion of long-term debt	6,360	6,360
Long-term debt excluding current maturities	970,580	971,362
Senior Credit Facility Due 2019 | Secured Debt | Term Loan
Debt Instrument [Line Items]
Long-term debt	610,051	610,845
Debt instrument original issue discount	13,239	14,035
Senior Note due 2020 | Senior Notes
Debt Instrument [Line Items]
Long-term debt	325,762	325,695
Debt instrument original issue discount	1,388	1,455
Stated interest rate on senior notes (in percent)	10.63%	10.63%	10.63%
Senior Notes Due 2020, Additional Notes | Senior Notes
Debt Instrument [Line Items]
Long-term debt	41,127	41,182
Stated interest rate on senior notes (in percent)	10.63%	10.63%
Debt instrument original issue premium	$1,127	$1,182

Longterm_Debt_Narrative_Detail

Long-term Debt - Narrative (Details) (USD $)	0 Months Ended
	Apr. 11, 2014	Apr. 11, 2014	Jun. 06, 2014	Mar. 31, 2015	Dec. 31, 2014	Jun. 06, 2012
Senior Credit Facility Due 2019
Line of Credit Facility [Line Items]
Senior credit facility maximum borrowing capacity	$679,700,000	$679,700,000
Minimum base rate (in percent)	2.25%
Minimum Eurodollar base rate (in percent)	1.25%
Senior Credit Facility Due 2019 | Prime Rate
Line of Credit Facility [Line Items]
Prime rate	prime rate
Senior Credit Facility Due 2019 | Federal Funds Purchased
Line of Credit Facility [Line Items]
Prime rate	federal funds
Basis spread on variable rate (in percent)	0.50%
Senior Credit Facility Due 2019 | One Month Eurodollar
Line of Credit Facility [Line Items]
Prime rate	one month Eurodollar rate
Basis spread on variable rate (in percent)	1.00%
Senior Credit Facility Due 2019 | Eurodollar
Line of Credit Facility [Line Items]
Prime rate	Eurodollar
Senior Credit Facility Due 2019 | Secured Debt | Term Loan
Line of Credit Facility [Line Items]
Credit Facility maturity term	5 years
Quarterly payments	1,600,000
Frequency of periodic payment	quarterly
Debt instrument original issue discount				13,239,000	14,035,000
Senior Credit Facility Due 2019 | Revolving Credit Facility
Line of Credit Facility [Line Items]
Revolving credit facility commitment fee on unused capacity (in percent)	0.50%
Senior Credit Facility Due 2019 | Revolving Credit Facility | Line of Credit
Line of Credit Facility [Line Items]
Senior credit facility maximum borrowing capacity	50,000,000	50,000,000
Credit Facility maturity term	5 years
Revolving credit facility remaining borrowing capacity				42,500,000
Senior Credit Facility Due 2019 | Letter of Credit
Line of Credit Facility [Line Items]
Long-term line of credit				7,500,000
Senior Credit Facility Due 2019 (Third Amendment)
Line of Credit Facility [Line Items]
Senior credit facility maximum borrowing capacity	679,700,000	679,700,000
Increase to line of credit borrowing limit	100,000,000	100,000,000
Senior Credit Facility Due 2019 (Third Amendment) | Secured Debt | Term Loan
Line of Credit Facility [Line Items]
Term loan facility principal amount	629,700,000	629,700,000
Quarterly payments	1,600,000
Proceeds from lines of credit	100,000,000
Number of payments	20
Amount of final payment	597,800,000	597,800,000
Senior Credit Facility Due 2019 (Third Amendment) | Revolving Credit Facility | Line of Credit
Line of Credit Facility [Line Items]
Senior credit facility maximum borrowing capacity	50,000,000	50,000,000
Senior Note due 2020 | Senior Notes
Line of Credit Facility [Line Items]
Debt instrument original issue discount				1,388,000	1,455,000
Stated interest rate on senior notes (in percent)				10.63%	10.63%	10.63%
Percentage of redemption price on Notes (in percent)			101.00%
Senior Note due 2020 | Senior Notes | Prior to June 1, 2016
Line of Credit Facility [Line Items]
Percentage of redemption price on Notes (in percent)			100.00%
Senior Note due 2020 | Senior Notes | On or after June 1, 2016
Line of Credit Facility [Line Items]
Percentage of redemption price on Notes (in percent)			105.31%
Senior Note due 2020 | Senior Notes | One or after June 1, 2018
Line of Credit Facility [Line Items]
Percentage of redemption price on Notes (in percent)			100.00%
Senior Note due 2020 | Senior Notes | Prior to June 1, 2015
Line of Credit Facility [Line Items]
Percentage of redemption price on Notes (in percent)			110.63%
Maximum redemption percentage of aggregate principal amount			35.00%
Senior Notes Due 2020, Additional Notes | Senior Notes
Line of Credit Facility [Line Items]
Stated interest rate on senior notes (in percent)				10.63%	10.63%
Proceeds from Issuance of Senior Long-term Debt		$40,000,000

Longterm_Debt_Maturities_of_Lo

Long-term Debt - Maturities of Long-term Debt (Details) (USD $)	Mar. 31, 2015
In Thousands, unless otherwise specified
Debt Disclosure [Abstract]
For the twelve months ended March 31, 2016	$6,360
For the twelve months ended March 31, 2017	6,360
For the twelve months ended March 31, 2018	6,360
For the twelve months ended March 31, 2019	6,360
For the twelve months ended March 31, 2020	584,611
Thereafter	366,889
Total long-term debt maturities	$976,940

Other_Operating_Expenses_Detai

Other Operating Expenses (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Other Income and Expenses [Abstract]
Severance and retention bonuses	$578	$562
Acquisition-related costs and other non-recurring charges	2,779	620
Asset write-off	6,000	4,706
Sponsor fee	981	641
Total other operating expenses	$10,338	$6,529

Segment_Information_Results_of

Segment Information - Results of Operations (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Segment Reporting Information [Line Items]
Operating Income (Loss)	($12,779)	($7,968)
Operating Segments
Segment Reporting Information [Line Items]
Revenues	143,515	118,262
Operating Income (Loss)	34,259	29,316
Operating Segments | Commercial
Segment Reporting Information [Line Items]
Revenues	118,380	96,350
Operating Income (Loss)	35,536	29,957
Operating Segments | Government
Segment Reporting Information [Line Items]
Revenues	25,135	21,912
Operating Income (Loss)	-1,277	-641
Center, Other
Segment Reporting Information [Line Items]
Revenues	-341	0
Operating Income (Loss)	-7,731	-6,350
Segment Operating Income
Segment Reporting Information [Line Items]
Revenues	143,174	118,262
Operating Income (Loss)	$26,528	$22,966
Segment operating Margin (percent)	19.00%	19.00%

Segment_Information_Reconcilia

Segment Information - Reconciliation to Net Income (Loss) (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating Income (Loss)	($12,779)	($7,968)
Depreciation	-5,135	-6,593
Amortization of developed technology and content	-10,809	-9,197
Amortization of other identifiable intangible assets	-13,025	-8,615
Other operating expenses	-10,338	-6,529
Net interest expense	-18,472	-16,273
Other finance costs	-469	-76
Loss before income taxes	-31,720	-24,317
Segment Operating Income
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]
Operating Income (Loss)	$26,528	$22,966

Sharebased_Compensation_Narrat

Share-based Compensation - Narrative (Details) (USD $)	1 Months Ended	3 Months Ended
In Thousands, unless otherwise specified	Oct. 31, 2012	Mar. 31, 2015	Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense recognized against additional paid in capital		$311
Membership Interest
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Estimated forfeiture rate (in percent)		10.00%
Compensation expense recognized against additional paid in capital		311	240
Period in which Class B Membership Interest expected to be recognized (in years)		4 years 3 months
Total unrecognized compensation costs		3,308
Class B Membership Interest
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum percentage of Membership Interest can be awarded to executive officers	6.25%
Vesting percentage on each of the first five anniversaries (in percent)	20.00%
Award vesting period (in years)	5 years
Vesting percentage upon change in control of company	100.00%
Estimated forfeiture rate (in percent)			10.00%
Percent of membership interest vested		1.70%	0.00%
Membership interest vested estimated fair value		$2,039
Class B-1 Membership Interest
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting percentage on each of the first five anniversaries (in percent)	20.00%
Award vesting period (in years)	5 years
Vesting percentage upon change in control of company	100.00%

Sharebased_Compensation_Transa

Share-based Compensation - Transaction Related to Class B Membership Interest (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Class B Membership Interest
Ownership Interest (%)
Ownership interest percent	4.40%	4.40%
Ownership interest percent, outstanding and vested	1.70%
Fair Value at Grant Date (USD)
Membership interest fair value at grant date	$6,100	$6,100
Membership interest fair value at grant date, outstanding and vested	2,391
Class B-1 Membership Interest
Ownership Interest (%)
Ownership interest percent	0.90%	0.90%
Ownership interest percent, outstanding and vested	0.00%
Fair Value at Grant Date (USD)
Membership interest fair value at grant date	1,067	1,067
Membership interest fair value at grant date, outstanding and vested	$0

Related_Party_Transactions_Nar

Related Party Transactions - Narrative (Details) (USD $)	3 Months Ended		0 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Oct. 11, 2013
Related Party Transaction [Line Items]
Sponsor advisory fees	$981,000	$641,000
Sponsor advisory fee payable	300,000
Thomson Reuters
Related Party Transaction [Line Items]
Minimum annual advisory fee payment to Sponsor	2,500,000
Percentage of consolidated EBITDA for advisory fee calculation (in percent)	2.00%
Thomson Reuters U.S. Inc | Reverse Transitional Services Agreement
Related Party Transaction [Line Items]
Income from service agreement reported as a reduction to General and administrative expense	100,000	100,000
Holdings, LLC
Related Party Transaction [Line Items]
Additional capital contribution	3,730,000
Related party receivable			$300,000
Interest rate on receivable			1.90%
Receivable redemption percentage			100.00%

Income_Taxes_Narrative_Details

Income Taxes - Narrative (Details) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Income Tax Disclosure [Abstract]
Effective income tax rate	-0.90%	20.80%
Federal income tax rate	35.00%	35.00%
Deferred tax assets valuation allowance	$8

Commitment_and_Contingencies_N

Commitment and Contingencies - Narrative (Details) (USD $)	3 Months Ended		12 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2007	Jan. 02, 2013
	Motion
Long-term Purchase Commitment [Line Items]
Revenue share asset written off	$6,000,000	$4,706,000
Number of dispositive motion to dismiss all the actions	1
Pacific Alliance Medical Center Case
Long-term Purchase Commitment [Line Items]
Reimbursement claims lost by third party			600,000
Minimum | Reglan Case
Long-term Purchase Commitment [Line Items]
Number of pharmaceutical tort lawsuits	200
Revenue Share with Supplier | Minimum
Long-term Purchase Commitment [Line Items]
Revenue share minimum amount guaranteed by the Company in 2013				2,000,000
Revenue share minimum amount guaranteed by the Company in 2014				4,000,000
Revenue share minimum amount guaranteed by the Company in 2015				$6,000,000

Fair_Value_Measurement_Details

Fair Value Measurement (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Jun. 06, 2012
In Thousands, unless otherwise specified
Senior Note due 2020 | Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Stated interest rate on senior notes (in percent)	10.63%	10.63%	10.63%
Level 1 | Senior Credit Facility Due 2019 | Term Loan | Secured Debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair values	0	0
Level 1 | Senior Note due 2020 | Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair values	0	0
Level 2 | Senior Credit Facility Due 2019 | Term Loan | Secured Debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair values	625,596	603,009
Level 2 | Senior Note due 2020 | Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair values	386,425	357,971
Level 3 | Senior Credit Facility Due 2019 | Term Loan | Secured Debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair values	0	0
Level 3 | Senior Note due 2020 | Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair values	0	0
Reported Value Measurement | Senior Credit Facility Due 2019 | Term Loan | Secured Debt
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair values	610,051	610,845
Reported Value Measurement | Senior Note due 2020 | Senior Notes
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair values	366,889	366,877

Supplemental_Guarantor_Financi2

Supplemental Guarantor Financial Information - Narrative (Details) (USD $)	0 Months Ended	3 Months Ended
In Thousands, unless otherwise specified	Jun. 06, 2012	Mar. 31, 2015	Apr. 10, 2014
			Subsidiary-guarantor
Condensed Financial Statements, Captions [Line Items]
Ownership percentage wholly owned subsidiary		100.00%
Number of subsidiary guarantors			0
Thomson Reuters (Healthcare) Inc. (TRHI)
Condensed Financial Statements, Captions [Line Items]
Acquisition related costs	$26,734
Maximum
Condensed Financial Statements, Captions [Line Items]
Subsidiary percentage of company consolidated amounts		3.00%

Supplemental_Guarantor_Financi3

Supplemental Guarantor Financial Information - Balance Sheet (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014	Mar. 31, 2014	Dec. 31, 2013
In Thousands, unless otherwise specified
Assets
Cash and cash equivalents	$28,287	$12,604	$12,977	$10,255
Trade and other receivables, net of allowances	103,671	120,214
Prepaid expenses and other current assets	28,220	30,251
Deferred tax assets	443	621
Intercompany receivable	0	0
Total current assets	160,621	163,690
Investment in subsidiaries	0	0
Computer hardware and other property, net	34,035	37,435
Developed technology and content, net	129,496	134,078
Goodwill	498,820	498,820
Other identifiable intangible assets, net	369,854	382,879
Other noncurrent assets	15,369	16,187
Total assets	1,208,195	1,233,089
Liabilities and Equity
Accounts payable and accrued expenses	68,468	67,228
Deferred revenue	135,097	129,129
Current portion of long-term debt	6,360	6,360
Capital lease obligation	673	664
Deferred tax liability	0	0
Current taxes payable	43	173
Intercompany payable	0	0
Total current liabilities	210,641	203,554
Deferred revenue	6,306	5,456
Capital lease obligation	1,203	1,374
Long-term debt	970,580	971,362
Deferred tax liabilities	443	621
Other noncurrent liabilities	3,420	3,599
Total liabilities	1,192,593	1,185,966
Equity
Common stock	0	0
Additional paid-in capital	483,861	483,550
Accumulated deficit	-468,133	-436,123
Foreign currency translation adjustment	-126	-304
Total equity	15,602	47,123
Total liabilities and equity	1,208,195	1,233,089
Parent
Assets
Cash and cash equivalents	0	0
Trade and other receivables, net of allowances	0	0
Prepaid expenses and other current assets	0	0
Deferred tax assets	0	0
Intercompany receivable	0	0
Total current assets	0	0
Investment in subsidiaries	15,602	47,123
Computer hardware and other property, net	0	0
Developed technology and content, net	0	0
Goodwill	0	0
Other identifiable intangible assets, net	0	0
Other noncurrent assets	0	0
Total assets	15,602	47,123
Liabilities and Equity
Accounts payable and accrued expenses	0	0
Deferred revenue	0	0
Current portion of long-term debt	0	0
Capital lease obligation	0	0
Deferred tax liability	0	0
Current taxes payable	0	0
Intercompany payable	0	0
Total current liabilities	0	0
Deferred revenue	0	0
Capital lease obligation	0	0
Long-term debt	0	0
Deferred tax liabilities	0	0
Other noncurrent liabilities	0	0
Total liabilities	0	0
Equity
Common stock	0	0
Additional paid-in capital	483,861	483,550
Accumulated deficit	-468,133	-436,123
Foreign currency translation adjustment	-126	-304
Total equity	15,602	47,123
Total liabilities and equity	15,602	47,123
Issuer
Assets
Cash and cash equivalents	22,494	8,243
Trade and other receivables, net of allowances	89,249	106,181
Prepaid expenses and other current assets	26,261	28,574
Deferred tax assets	443	621
Intercompany receivable	26,815	23,297
Total current assets	165,262	166,916
Investment in subsidiaries	106,863	109,851
Computer hardware and other property, net	33,145	36,459
Developed technology and content, net	123,386	128,917
Goodwill	457,677	457,677
Other identifiable intangible assets, net	318,939	327,554
Other noncurrent assets	15,355	15,951
Total assets	1,220,627	1,243,325
Liabilities and Equity
Accounts payable and accrued expenses	58,834	58,777
Deferred revenue	126,418	121,903
Current portion of long-term debt	6,360	6,360
Capital lease obligation	673	664
Deferred tax liability	0	0
Current taxes payable	0	0
Intercompany payable	30,915	26,086
Total current liabilities	223,200	213,790
Deferred revenue	6,179	5,456
Capital lease obligation	1,203	1,374
Long-term debt	970,580	971,362
Deferred tax liabilities	443	621
Other noncurrent liabilities	3,420	3,599
Total liabilities	1,205,025	1,196,202
Equity
Common stock	0	0
Additional paid-in capital	483,861	483,550
Accumulated deficit	-468,133	-436,123
Foreign currency translation adjustment	-126	-304
Total equity	15,602	47,123
Total liabilities and equity	1,220,627	1,243,325
Guarantor subsidiaries
Assets
Cash and cash equivalents	3,957	3,264
Trade and other receivables, net of allowances	13,032	12,765
Prepaid expenses and other current assets	1,026	817
Deferred tax assets	0	0
Intercompany receivable	41,716	39,194
Total current assets	59,731	56,040
Investment in subsidiaries	-78	-192
Computer hardware and other property, net	178	207
Developed technology and content, net	6,110	5,161
Goodwill	41,143	41,143
Other identifiable intangible assets, net	50,915	55,325
Other noncurrent assets	0	0
Total assets	157,999	157,684
Liabilities and Equity
Accounts payable and accrued expenses	7,003	5,931
Deferred revenue	8,361	6,802
Current portion of long-term debt	0	0
Capital lease obligation	0	0
Deferred tax liability	0	0
Current taxes payable	32	0
Intercompany payable	37,132	35,784
Total current liabilities	52,528	48,517
Deferred revenue	127	0
Capital lease obligation	0	0
Long-term debt	0	0
Deferred tax liabilities	0	0
Other noncurrent liabilities	0	0
Total liabilities	52,655	48,517
Equity
Common stock	0	0
Additional paid-in capital	114,090	114,483
Accumulated deficit	-8,782	-5,275
Foreign currency translation adjustment	36	-41
Total equity	105,344	109,167
Total liabilities and equity	157,999	157,684
Non-Guarantor subsidiaries
Assets
Cash and cash equivalents	1,836	1,097
Trade and other receivables, net of allowances	1,390	1,268
Prepaid expenses and other current assets	933	860
Deferred tax assets	0	0
Intercompany receivable	48,758	46,799
Total current assets	52,917	50,024
Investment in subsidiaries	0	0
Computer hardware and other property, net	712	769
Developed technology and content, net	0	0
Goodwill	0	0
Other identifiable intangible assets, net	0	0
Other noncurrent assets	14	236
Total assets	53,643	51,029
Liabilities and Equity
Accounts payable and accrued expenses	2,631	2,520
Deferred revenue	318	424
Current portion of long-term debt	0	0
Capital lease obligation	0	0
Deferred tax liability	0	0
Current taxes payable	11	173
Intercompany payable	49,242	47,420
Total current liabilities	52,202	50,537
Deferred revenue	0	0
Capital lease obligation	0	0
Long-term debt	0	0
Deferred tax liabilities	0	0
Other noncurrent liabilities	0	0
Total liabilities	52,202	50,537
Equity
Common stock	0	0
Additional paid-in capital	-125	-125
Accumulated deficit	1,871	1,130
Foreign currency translation adjustment	-305	-513
Total equity	1,441	492
Total liabilities and equity	53,643	51,029
Eliminations
Assets
Cash and cash equivalents	0	0
Trade and other receivables, net of allowances	0	0
Prepaid expenses and other current assets	0	0
Deferred tax assets	0	0
Intercompany receivable	-117,289	-109,290
Total current assets	-117,289	-109,290
Investment in subsidiaries	-122,387	-156,782
Computer hardware and other property, net	0	0
Developed technology and content, net	0	0
Goodwill	0	0
Other identifiable intangible assets, net	0	0
Other noncurrent assets	0	0
Total assets	-239,676	-266,072
Liabilities and Equity
Accounts payable and accrued expenses	0	0
Deferred revenue	0	0
Current portion of long-term debt	0	0
Capital lease obligation	0	0
Deferred tax liability	0	0
Current taxes payable	0	0
Intercompany payable	-117,289	-109,290
Total current liabilities	-117,289	-109,290
Deferred revenue	0	0
Capital lease obligation	0	0
Long-term debt	0	0
Deferred tax liabilities	0	0
Other noncurrent liabilities	0	0
Total liabilities	-117,289	-109,290
Equity
Common stock	0	0
Additional paid-in capital	-597,826	-597,908
Accumulated deficit	475,044	440,268
Foreign currency translation adjustment	395	858
Total equity	-122,387	-156,782
Total liabilities and equity	($239,676)	($266,072)

Supplemental_Guarantor_Financi4

Supplemental Guarantor Financial Information - Statement of Operations (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Condensed Income Statements, Captions [Line Items]
Revenues, net	$143,173	$118,262
Operating costs and expenses Cost of revenues, excluding depreciation and amortization	-83,829	-70,287
Selling and marketing, excluding depreciation and amortization	-15,934	-13,724
General and administrative, excluding depreciation and amortization	-16,882	-11,285
Depreciation	-5,135	-6,593
Amortization of developed technology and content	-10,809	-9,197
Amortization of other identifiable intangible assets	-13,025	-8,615
Other operating expenses	-10,338	-6,529
Total operating costs and expenses	-155,952	-126,230
Operating loss	-12,779	-7,968
Net interest expense	-18,472	-16,273
Other finance costs	-469	-76
Equity in net income (loss) of subsidiaries	0
Loss before income taxes	-31,720	-24,317
Benefit from (provision for) income taxes	-290	5,060
Net loss	-32,010	-19,257
Foreign currency translation adjustments	178	-139
Total comprehensive loss	-31,832	-19,396
Parent
Condensed Income Statements, Captions [Line Items]
Revenues, net	0
Operating costs and expenses Cost of revenues, excluding depreciation and amortization	0
Selling and marketing, excluding depreciation and amortization	0
General and administrative, excluding depreciation and amortization	0
Depreciation	0
Amortization of developed technology and content	0
Amortization of other identifiable intangible assets	0
Other operating expenses	0
Total operating costs and expenses	0
Operating loss	0
Net interest expense	0
Other finance costs	0
Equity in net income (loss) of subsidiaries	-32,010
Loss before income taxes	-32,010
Benefit from (provision for) income taxes	0
Net loss	-32,010
Foreign currency translation adjustments	178
Total comprehensive loss	-31,832
Issuer
Condensed Income Statements, Captions [Line Items]
Revenues, net	123,304
Operating costs and expenses Cost of revenues, excluding depreciation and amortization	-74,939
Selling and marketing, excluding depreciation and amortization	-12,720
General and administrative, excluding depreciation and amortization	-11,372
Depreciation	-5,006
Amortization of developed technology and content	-10,563
Amortization of other identifiable intangible assets	-8,615
Other operating expenses	-10,588
Total operating costs and expenses	-133,803
Operating loss	-10,499
Net interest expense	-18,469
Other finance costs	-270
Equity in net income (loss) of subsidiaries	-2,772
Loss before income taxes	-32,010
Benefit from (provision for) income taxes	0
Net loss	-32,010
Foreign currency translation adjustments	178
Total comprehensive loss	-31,832
Guarantor subsidiaries
Condensed Income Statements, Captions [Line Items]
Revenues, net	16,663
Operating costs and expenses Cost of revenues, excluding depreciation and amortization	-9,474
Selling and marketing, excluding depreciation and amortization	-1,472
General and administrative, excluding depreciation and amortization	-4,255
Depreciation	-29
Amortization of developed technology and content	-246
Amortization of other identifiable intangible assets	-4,410
Other operating expenses	-91
Total operating costs and expenses	-19,977
Operating loss	-3,314
Net interest expense	1
Other finance costs	-116
Equity in net income (loss) of subsidiaries	6
Loss before income taxes	-3,423
Benefit from (provision for) income taxes	-84
Net loss	-3,507
Foreign currency translation adjustments	77
Total comprehensive loss	-3,430
Non-Guarantor subsidiaries
Condensed Income Statements, Captions [Line Items]
Revenues, net	5,938
Operating costs and expenses Cost of revenues, excluding depreciation and amortization	-1,807
Selling and marketing, excluding depreciation and amortization	-1,742
General and administrative, excluding depreciation and amortization	-1,255
Depreciation	-100
Amortization of developed technology and content	0
Amortization of other identifiable intangible assets	0
Other operating expenses	0
Total operating costs and expenses	-4,904
Operating loss	1,034
Net interest expense	-4
Other finance costs	-83
Equity in net income (loss) of subsidiaries	0
Loss before income taxes	947
Benefit from (provision for) income taxes	-206
Net loss	741
Foreign currency translation adjustments	208
Total comprehensive loss	949
Eliminations
Condensed Income Statements, Captions [Line Items]
Revenues, net	-2,732
Operating costs and expenses Cost of revenues, excluding depreciation and amortization	2,391
Selling and marketing, excluding depreciation and amortization	0
General and administrative, excluding depreciation and amortization	0
Depreciation	0
Amortization of developed technology and content	0
Amortization of other identifiable intangible assets	0
Other operating expenses	341
Total operating costs and expenses	2,732
Operating loss	0
Net interest expense	0
Other finance costs	0
Equity in net income (loss) of subsidiaries	34,776
Loss before income taxes	34,776
Benefit from (provision for) income taxes	0
Net loss	34,776
Foreign currency translation adjustments	-463
Total comprehensive loss	$34,313

Supplemental_Guarantor_Financi5

Supplemental Guarantor Financial Information - Cash Flow (Details) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Operating activities
Net income (loss)	($32,010)	($19,257)
Non-cash adjustments	36,822
Changes in operating assets and liabilities	24,892
Net cash provided by operating activities	29,704	30,617
Investing activities
Acquisition - payment of working capital adjustment	-91	0
Capital expenditures	-12,355	-10,299
Net cash used in investing activities	-12,446	-10,299
Financing activities
Intercompany transaction	0
Principal repayment of senior term loan	-1,590	-1,338
Payment of capital lease obligation	-163	-1,120
Net cash used in financing activities	-1,753	-17,458
Effect of exchange rate changes in cash and cash equivalents	178	-138
Increase in cash and cash equivalents	15,683	2,722
Cash and cash equivalents
Beginning of period	12,604	10,255
End of period	28,287	12,977
Parent
Operating activities
Net income (loss)	-32,010
Non-cash adjustments	32,010
Changes in operating assets and liabilities	0
Net cash provided by operating activities	0
Investing activities
Acquisition - payment of working capital adjustment	0
Capital expenditures	0
Net cash used in investing activities	0
Financing activities
Intercompany transaction	0
Principal repayment of senior term loan	0
Payment of capital lease obligation	0
Net cash used in financing activities	0
Effect of exchange rate changes in cash and cash equivalents	0
Increase in cash and cash equivalents	0
Cash and cash equivalents
Beginning of period	0
End of period	0
Issuer
Operating activities
Net income (loss)	-32,010
Non-cash adjustments	34,809
Changes in operating assets and liabilities	23,101
Net cash provided by operating activities	25,900
Investing activities
Acquisition - payment of working capital adjustment	-91
Capital expenditures	-11,116
Net cash used in investing activities	-11,207
Financing activities
Intercompany transaction	1,311
Principal repayment of senior term loan	-1,590
Payment of capital lease obligation	-163
Net cash used in financing activities	-442
Effect of exchange rate changes in cash and cash equivalents	0
Increase in cash and cash equivalents	14,251
Cash and cash equivalents
Beginning of period	8,243
End of period	22,494
Guarantor subsidiaries
Operating activities
Net income (loss)	-3,507
Non-cash adjustments	4,679
Changes in operating assets and liabilities	1,921
Net cash provided by operating activities	3,093
Investing activities
Acquisition - payment of working capital adjustment	0
Capital expenditures	-1,196
Net cash used in investing activities	-1,196
Financing activities
Intercompany transaction	-1,174
Principal repayment of senior term loan	0
Payment of capital lease obligation	0
Net cash used in financing activities	-1,174
Effect of exchange rate changes in cash and cash equivalents	-30
Increase in cash and cash equivalents	693
Cash and cash equivalents
Beginning of period	3,264
End of period	3,957
Non-Guarantor subsidiaries
Operating activities
Net income (loss)	741
Non-cash adjustments	100
Changes in operating assets and liabilities	-130
Net cash provided by operating activities	711
Investing activities
Acquisition - payment of working capital adjustment	0
Capital expenditures	-43
Net cash used in investing activities	-43
Financing activities
Intercompany transaction	-137
Principal repayment of senior term loan	0
Payment of capital lease obligation	0
Net cash used in financing activities	-137
Effect of exchange rate changes in cash and cash equivalents	208
Increase in cash and cash equivalents	739
Cash and cash equivalents
Beginning of period	1,097
End of period	1,836
Eliminations
Operating activities
Net income (loss)	34,776
Non-cash adjustments	-34,776
Changes in operating assets and liabilities	0
Net cash provided by operating activities	0
Investing activities
Acquisition - payment of working capital adjustment	0
Capital expenditures	0
Net cash used in investing activities	0
Financing activities
Intercompany transaction	0
Principal repayment of senior term loan	0
Payment of capital lease obligation	0
Net cash used in financing activities	0
Effect of exchange rate changes in cash and cash equivalents	0
Increase in cash and cash equivalents	0
Cash and cash equivalents
Beginning of period	0
End of period	$0